<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-id journal-id-type="pmc-domain-id">3848</journal-id><journal-id journal-id-type="pmc-domain">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title-group><journal-title>bioRxiv</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn><publisher><publisher-name>Cold Spring Harbor Laboratory Preprints</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11429896</article-id><article-id pub-id-type="pmcid-ver">PMC11429896.2</article-id><article-id pub-id-type="pmcaid">11429896</article-id><article-id pub-id-type="pmcaiid">11429896</article-id><article-id pub-id-type="pmid">39345519</article-id><article-id pub-id-type="doi">10.1101/2024.09.17.613469</article-id><article-version-alternatives><article-version article-version-type="pmc-version">2</article-version><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">2</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A chronic murine model of pulmonary <italic toggle="yes">Acinetobacter baumannii</italic> infection enabling the investigation of late virulence factors, long-term antibiotic treatments, and polymicrobial infections</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jackson-Litteken</surname><given-names initials="CD">Clay D.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Venanzio</surname><given-names initials="G">Gisela</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Janet-Maitre</surname><given-names initials="M">Manon</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Castro</surname><given-names initials="&#xCD;A">&#205;talo A.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mackel</surname><given-names initials="JJ">Joseph J.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rosen</surname><given-names initials="DA">David A.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7669-6572</contrib-id><name name-style="western"><surname>L&#243;pez</surname><given-names initials="CB">Carolina B.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feldman</surname><given-names initials="MF">Mario F.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri, USA.</aff><aff id="A2"><label>2</label>Center for Women&#8217;s Infectious Diseases Research, Washington University School of Medicine, Saint Louis, Missouri, USA.</aff><aff id="A3"><label>3</label>Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri, USA.</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>9</month><year>2024</year></pub-date><issue-id pub-id-type="pmc-issue-id">471597</issue-id><elocation-id>2024.09.17.613469</elocation-id><pub-history><event event-type="pmc-release"><date><day>27</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-23 02:25:31.253"><day>23</day><month>10</month><year>2024</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</ext-link>, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihpp-2024.09.17.613469v2.pdf"/><self-uri content-type="pdf">nihpp-2024.09.17.613469.pdf</self-uri><abstract id="ABS1"><p id="P1"><italic toggle="yes">Acinetobacter baumannii</italic> can cause prolonged infections that disproportionately affect immunocompromised populations. Our understanding of <italic toggle="yes">A. baumannii</italic> respiratory pathogenesis relies on an acute murine infection model with limited clinical relevance that employs an unnaturally high number of bacteria and requires the assessment of bacterial load at 24&#8211;36 hours post-infection. Here, we demonstrate that low intranasal inoculums in immunocompromised mice with a <italic toggle="yes">tlr4</italic> mutation leads to reduced inflammation, allowing for persistent infections lasting at least 3 weeks. Using this &#8220;chronic infection model,&#8221; we determined the adhesin InvL is an imperative virulence factor required during later stages of infection, despite being dispensable in the early phase. We also demonstrate that the chronic model enables the distinction between antibiotics that, although initially reduce bacterial burden, either lead to complete clearance or result in the formation of bacterial persisters. To illustrate how our model can be applied to study polymicrobial infections, we inoculated mice with an active <italic toggle="yes">A. baumannii</italic> infection with <italic toggle="yes">Staphylococcus aureus</italic> or <italic toggle="yes">Klebsiella pneumoniae</italic>. We found that <italic toggle="yes">S. aureus</italic> exacerbates the infection, while <italic toggle="yes">K. pneumoniae</italic> enhances <italic toggle="yes">A. baumannii</italic> clearance. In all, the chronic model overcomes some limitations of the acute pulmonary model, expanding our capabilities to study of <italic toggle="yes">A. baumannii</italic> pathogenesis and lays the groundwork for the development of similar models for other important opportunistic pathogens.</p></abstract><kwd-group><kwd><italic toggle="yes">Acinetobacter baumannii</italic></kwd><kwd>Murine model</kwd><kwd>Virulence factors</kwd><kwd>Antibiotic treatments</kwd><kwd>Polymicrobial infections</kwd><kwd>Pathogenesis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P2"><italic toggle="yes">Acinetobacter baumannii</italic> is a Gram-negative opportunistic pathogen that causes diverse infections including pneumonia, <underline>u</underline>rinary <underline>t</underline>ract <underline>i</underline>nfection (UTI), bone and soft tissue infection, and septicemia (<xref rid="R1" ref-type="bibr">1</xref>&#8211;<xref rid="R5" ref-type="bibr">5</xref>). While becoming an increasingly more common cause of community-acquired infections, <italic toggle="yes">A. baumannii</italic> still primarily causes hospital-acquired infections in critically ill and immunocompromised patients, ~25% of which are polymicrobial (<xref rid="R6" ref-type="bibr">6</xref>&#8211;<xref rid="R11" ref-type="bibr">11</xref>). These infections are associated with an alarming mortality rate, up to 80% in some populations, largely owing to extremely high rates of multi-drug resistance (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>). Notably, <italic toggle="yes">A. baumannii</italic> isolates exhibit the highest rates of multi-drug resistance of all Gram-negative pathogens, leading the World Health Organization to classify the bacterium at its highest priority for research and development of new treatments (<xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R14" ref-type="bibr">14</xref>). There is consequently an urgent need to better understand the virulence mechanisms employed by <italic toggle="yes">A. baumannii</italic> to guide the development of novel therapeutic approaches to combat infections.</p><p id="P3">While <italic toggle="yes">A. baumannii</italic> can cause a variety of infections, it is most commonly associated with pneumonia (<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R15" ref-type="bibr">15</xref>). In fact, <italic toggle="yes">A. baumannii</italic> causes up to 10% of all <underline>h</underline>ospital-<underline>a</underline>cquired <underline>p</underline>neumonia (HAP) cases in the United States, highlighting its importance in clinical settings (<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>). Despite this, little is known regarding the pathogenesis of this bacterium in the respiratory tract (<xref rid="R18" ref-type="bibr">18</xref>). A major hindrance in the ability to investigate <italic toggle="yes">A. baumannii</italic> pneumonia is the lack of available clinically-relevant murine infection models. This is, in large part, due to the low virulence of most strains in immunocompetent mice. This is a shared feature among many pathogens that commonly cause HAP, including <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Staphylococcus aureus</italic>, for which animal models closely mimicking human infection are not available (<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>). An acute infection model requiring a very high, and rather artificial, inoculum of 10<sup>8</sup>-10<sup>9</sup> bacteria introduced intranasally or intratracheally is most often used to investigate these pathogens (<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>). <underline>W</underline>ild <underline>t</underline>ype (WT) mice will typically either succumb to infection or clear the organism by 72 h, thus requiring early readouts of infection such as bacterial pulmonary titers at 24&#8211;36 h. While this model may serve as a useful tool to study pathogenesis early during infection, the quick bacterial clearance does not allow for the study of bacterial virulence mechanisms at later timepoints. Importantly, <italic toggle="yes">A. baumannii</italic> respiratory infection in humans results in an average length of hospital stay of ~30 days, and this number is much higher in cases caused by multi-drug resistant strains, highlighting the need for a long-term infection model (<xref rid="R22" ref-type="bibr">22</xref>, <xref rid="R23" ref-type="bibr">23</xref>). In this pursuit, some laboratories have used antibody or cyclophosphamide treatments to render mice neutropenic (<xref rid="R24" ref-type="bibr">24</xref>&#8211;<xref rid="R30" ref-type="bibr">30</xref>). These treatments initially make mice more susceptible to <italic toggle="yes">A. baumannii</italic> infection, enabling the study of bacterial pathogenesis up to 7 <underline>d p</underline>ost-<underline>i</underline>nfection (dpi) using lower inoculums (~10<sup>7</sup> bacteria). However, these models do not achieve stable neutropenia in mice which leads to clearance of infection. To maintain neutropenia over longer periods, multiple injections would be necessary, which can lead to fluctuating neutrophil levels, thereby altering the overall course of disease. A notable caveat to many reports using these currently available immunocompetent and immunocompromised infection models is that older, lab-domesticated strains and non-lung isolates, such as <italic toggle="yes">Ab</italic>19606 and <italic toggle="yes">Ab</italic>17978, are employed, despite the extensive literature demonstrating numerous genotypic and phenotypic differences between these and modern respiratory isolates (<xref rid="R31" ref-type="bibr">31</xref>&#8211;<xref rid="R35" ref-type="bibr">35</xref>). In all, there is an urgent need for alternative infection models to study bacterial pathogenesis during long-term infection by relevant clinical isolates.</p><p id="P4">Previous reports have used genetically immunocompromised mice to study the role of the host immune response to <italic toggle="yes">A. baumannii</italic> infection. One example is mice carrying a mutation in <underline>t</underline>oll-<underline>l</underline>ike <underline>r</underline>eceptor 4 (TLR4). TLR4 recognizes the lipid A moiety of bacterial <underline>l</underline>ipo<underline>p</underline>oly<underline>s</underline>accharide (LPS) and <underline>l</underline>ipo<underline>o</underline>ligo<underline>s</underline>accharide (LOS), the main component of the outer membrane of most Gram-negative bacteria (<xref rid="R36" ref-type="bibr">36</xref>&#8211;<xref rid="R38" ref-type="bibr">38</xref>). The recognition of lipid A by TLR4 triggers a signaling cascade through MyD88- or TRIF-dependent pathways, resulting in increased inflammatory cytokine and type 1 interferon production, respectively (<xref rid="R39" ref-type="bibr">39</xref>). The role of TLR4 during <italic toggle="yes">A. baumannii</italic> infection has been examined in murine septicemia, acute pneumonia, UTI, and <underline>c</underline>atheter-<underline>a</underline>ssociated <underline>UTI</underline> (CAUTI) models (<xref rid="R40" ref-type="bibr">40</xref>&#8211;<xref rid="R42" ref-type="bibr">42</xref>). In the acute pneumonia model, Knapp et al. showed that <italic toggle="yes">tlr4</italic> mutant mice had increased <italic toggle="yes">A. baumannii</italic> CFU in the lungs with reduced inflammatory cytokines compared to WT mice (<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R43" ref-type="bibr">43</xref>). Using a bloodstream infection model, Lin et al. demonstrated that WT C3H/FeJ and <italic toggle="yes">tlr4</italic> mutant C3H/HeJ mice had similar bacterial burdens (<xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R44" ref-type="bibr">44</xref>). However, all WT mice succumbed to infection by day 4, whereas all <italic toggle="yes">tlr4</italic> mutant mice survived. This could be attributed to WT mice experiencing septic shock associated with increased inflammatory cytokines. Finally, in a UTI model, our laboratory found that <italic toggle="yes">tlr4</italic> mutant C3H/HeJ mice were more susceptible to infection than WT C3H/HeN mice (<xref rid="R42" ref-type="bibr">42</xref>). Moreover, we found that C3H/HeJ mice in the UTI model formed small intracellular populations in urothelial cells referred to as <underline><italic toggle="yes">A</italic></underline><italic toggle="yes">cinetobacter</italic>
<underline><italic toggle="yes">b</italic></underline><italic toggle="yes">aumannii</italic>
<underline>i</underline>ntracellular <underline>r</underline>eservoirs (ABIRs), which could seed a recurrent infection upon catheterization at higher rates relative to WT mice. In addition to playing a significant role during murine infection, TLR4 is relevant in clinical settings as well. In fact, numerous studies have identified links between <italic toggle="yes">tlr4</italic> polymorphisms and infection outcomes from <italic toggle="yes">A. baumannii</italic> pneumonia (<xref rid="R45" ref-type="bibr">45</xref>&#8211;<xref rid="R47" ref-type="bibr">47</xref>). In all, these studies demonstrate the key role of TLR4 in controlling <italic toggle="yes">A. baumannii</italic> infection and disease progression and highlight the clinical relevance of the associated signaling cascade.</p><p id="P5">In this work we describe a novel murine model of <italic toggle="yes">A. baumannii</italic> pneumonia that employs <italic toggle="yes">tlr4</italic> mutant mice and low bacterial inoculums (10<sup>5</sup> bacteria). Using this model, we show that clinically-relevant <italic toggle="yes">A. baumannii</italic> strains can establish chronic infection. We additionally demonstrate that our model enables the discovery of virulence factors not detectable in the acute infection model. Finally, we illustrate how our model can be employed to assess the efficacy of antibiotics over the course of infection and investigate polymicrobial infections.</p></sec><sec id="S2"><title>Results</title><sec id="S3"><title>tlr4 mutant mice are susceptible to chronic infection at low inoculums.</title><p id="P6">To assess if <italic toggle="yes">tlr4</italic> mutant mice could serve as permissive hosts for long-term respiratory infection, we performed intranasal inoculations of WT (C3H/HeN) and <italic toggle="yes">tlr4</italic> mutant (C3H/HeJ) mice with high (10<sup>8</sup>) and low (10<sup>5</sup>) inoculums of a modern <italic toggle="yes">A. baumannii</italic> respiratory isolate, G636, and sacrificed groups of mice every 3 days starting at 24 <underline>h</underline>ours <underline>p</underline>ost-<underline>i</underline>nfection (hpi). At the higher inoculum, WT mice cleared infection by day 4, consistent with previously published results using the acute pulmonary infection model (<xref rid="F1" ref-type="fig">Fig. 1A</xref>) (<xref rid="R21" ref-type="bibr">21</xref>). <italic toggle="yes">tlr4</italic> mutant mice infected with the higher inoculum also cleared infection relatively early after inoculation, with most mice having no detectable bacteria in the lungs by ~7 dpi. Strikingly, while WT mice infected with the lower dose of 10<sup>5</sup> bacteria cleared infection after 1 day, <italic toggle="yes">tlr4</italic> mutant mice maintained detectable bacteria in the lungs out to the latest timepoint tested, 19 dpi (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). Despite this long infection course, dissemination to distal organs was rarely detected. This is consistent with the clinical manifestations of non-ventilator <italic toggle="yes">A. baumannii</italic> pneumonia, as less than 20% of patients will develop subsequent bacteremia (<xref rid="R48" ref-type="bibr">48</xref>). Notably, by employing confocal microscopy, we were able to visualize bacteria in <italic toggle="yes">tlr4</italic> mutant mice with the low inoculum; at early timepoints (4 hpi and 2 dpi), bacteria were identified inside cells in the <underline>b</underline>roncho<underline>a</underline>lveolar <underline>l</underline>avage <underline>f</underline>luid (BALF), as well as extracellularly, consistent with our previously published results in the acute infection model (<xref rid="SD1" ref-type="supplementary-material">Fig. S1</xref>) (<xref rid="R31" ref-type="bibr">31</xref>).</p><p id="P7">We then assessed if a second modern <italic toggle="yes">A. baumannii</italic> respiratory isolate, G654, behaves similarly to G636 (<xref rid="F1" ref-type="fig">Fig. 1E</xref>). Again, detectable levels of bacteria were present in the lungs out to 19 dpi with the low inoculum in <italic toggle="yes">tlr4</italic> mutant mice, while WT mice cleared this inoculum within 1 day. At the higher inoculum, G654 was cleared soon after inoculation regardless of TLR4 functionality (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). On the contrary, when we tested an older, lab-domesticated urinary isolate that is commonly used to study <italic toggle="yes">A. baumannii</italic> respiratory pathogenesis, <italic toggle="yes">Ab</italic>19606, we found that WT and <italic toggle="yes">tlr4</italic> mutant mice cleared infection after 1 day regardless of inoculum size or mouse background (<xref rid="F1" ref-type="fig">Fig. 1C</xref> and <xref rid="F1" ref-type="fig">1F</xref>). In all, these results indicate that modern <italic toggle="yes">A. baumannii</italic> respiratory isolates can cause infection out to nearly 3 weeks at lower and likely more clinically-relevant inoculums than previously used in the literature. The finding that <italic toggle="yes">Ab</italic>19606 was unable to establish long-term infection further highlights the differences between modern, infection site-specific isolates and lab-domesticated strains (<xref rid="R31" ref-type="bibr">31</xref>&#8211;<xref rid="R35" ref-type="bibr">35</xref>). Importantly, this infection duration with low inoculums of modern respiratory isolates in <italic toggle="yes">tlr4</italic> mutant mice is the longest reported for <italic toggle="yes">A. baumannii</italic> in any animal model to date. We therefore chose to further characterize these conditions as a model to study pulmonary pathogenesis, referred to hereafter as the &#8220;chronic respiratory infection model.&#8221;</p></sec><sec id="S4"><title>Lower A. baumannii inoculums result in a decreased immune response in tlr4 mutant mice.</title><p id="P8">Given the unexpected result that <italic toggle="yes">tlr4</italic> mutant mice exhibit chronic infection at lower inoculums, while WT and <italic toggle="yes">tlr4</italic> mutant mice clear infection at higher inoculums, we sought to characterize the host immune response in these different conditions. We intranasally infected groups of WT and <italic toggle="yes">tlr4</italic> mutant mice with 10<sup>5</sup> or 10<sup>8</sup> bacteria or mock infected them with <underline>p</underline>hosphate-<underline>b</underline>uffered <underline>s</underline>aline (PBS). Then, at early timepoints of 4 hpi and 2 dpi and a later timepoint of 7 dpi, BALF was collected for immune cell quantification (<xref rid="F2" ref-type="fig">Fig. 2</xref>). Regardless of timepoint, inoculum, or mouse background, few significant changes were observed in number of <underline>a</underline>lveolar <underline>m</underline>acrophages (AMs) (<xref rid="F2" ref-type="fig">Fig. 2A</xref>&#8211;<xref rid="F2" ref-type="fig">2C</xref>). In WT mice, the number of <underline>p</underline>oly<underline>m</underline>orpho<underline>n</underline>uclear leukocytes (PMNs) was increased with the higher inoculum relative to lower and mock inoculums at every timepoint (<xref rid="F2" ref-type="fig">Fig. 2D</xref>&#8211;<xref rid="F2" ref-type="fig">2F</xref>). Additionally, at the higher inoculum, WT mice had increased PMNs relative to <italic toggle="yes">tlr4</italic> mutant mice at every time point in line with previous results (<xref rid="R41" ref-type="bibr">41</xref>). Interestingly, at the lower inoculum, while PMN counts trended higher at 4 hpi for WT mice relative to <italic toggle="yes">tlr4</italic> mutant mice, no significant differences were noted between these groups at any timepoint. This result suggests that, despite neutrophil influx being a predominant mechanism of <italic toggle="yes">A. baumannii</italic> clearance, PMN numbers alone may not account for differences in clearance between WT and <italic toggle="yes">tlr4</italic> mutant mice at the lower inoculum (<xref rid="R49" ref-type="bibr">49</xref>&#8211;<xref rid="R55" ref-type="bibr">55</xref>).</p><p id="P9">To further evaluate the host response, we quantified 13 common inflammatory cytokines in the BALF (<xref rid="SD1" ref-type="supplementary-material">Table S1</xref>). At the higher inoculum, WT and <italic toggle="yes">tlr4</italic> mutant mice exhibited significantly increased levels of IL-1&#945;, IFN-&#947;, TNF-&#945;, MCP-1, IL-1&#946;, IL-6, and IL-17A early during infection relative to the lower inoculum while levels dissipated by 7 dpi, consistent with bacterial clearance (See <xref rid="F1" ref-type="fig">Fig. 1A</xref>). WT mice infected with the high inoculum had significantly increased levels of IFN-&#946; relative to <italic toggle="yes">tlr4</italic> mutant mice at 4 hpi and increased levels of IL-1&#945;, IFN-&#947;, TNF-&#945;, MCP-1, IL12-p70, IL-1&#946;, IL-6, IL-27, and IL17A at 2 dpi, likely leading to the earlier clearance observed. At the lower inoculum, although WT mice clear infection within nearly 24 h and <italic toggle="yes">tlr4</italic> mutant mice maintain infection out to at least three weeks, minimal significant differences in inflammatory cytokines were observed (See <xref rid="F1" ref-type="fig">Fig. 1D</xref>). In fact, the only significant difference noted was the increased levels of GM-CSF at 4 hpi in WT mice relative to <italic toggle="yes">tlr4</italic> mutant mice. Other inflammatory cytokines that trended higher at early timepoints in WT mice at the lower inoculum include the inflammasome-associated cytokines IL-1&#945; and IL-1&#946;, as well as TNF-&#945; and IL-6. These elevated levels of inflammatory cytokines early during infection in WT mice could possibly account for the earlier clearance. Later during infection, however, <italic toggle="yes">tlr4</italic> mutant mice had elevated, albeit not significantly higher, amounts of TNF-&#945;, IL-1&#945;, and IL-6 relative to WT mice, consistent with persistent infection.</p></sec><sec id="S5"><title>The chronic respiratory infection model results in lung pathology.</title><p id="P10">We next assessed if the chronic respiratory infection model is associated with lung pathology. <italic toggle="yes">tlr4</italic> mutant mice were infected with 10<sup>5</sup> G636 or mock infected with PBS, and mice were sacrificed at 4 hpi, 2 dpi, 7 dpi, 14 dpi, and 21 dpi. Lungs were then sectioned, stained with <underline>h</underline>ematoxylin and <underline>e</underline>osin (H&amp;E), and scored for pathological changes as previously described (<xref rid="F3" ref-type="fig">Fig. 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Fig. S2</xref>, and <xref rid="SD1" ref-type="supplementary-material">Fig. S3</xref>) (<xref rid="R56" ref-type="bibr">56</xref>). The chronic model resulted in significant increases in alveolitis, peribronchiolitis, smooth muscle hypertrophy, squamous epithelium metaplasia, and formation of <underline>b</underline>ronchus-<underline>a</underline>ssociated <underline>l</underline>ymphoid <underline>t</underline>issue (BALT) relative to mock-treated mice (<xref rid="F3" ref-type="fig">Fig. 3</xref> and <xref rid="SD1" ref-type="supplementary-material">Fig S2</xref>). Significant changes in goblet cell hyperplasia and fibrosis were not detected (<xref rid="SD1" ref-type="supplementary-material">Fig. S3</xref>). Of note, significant signs of disease were detected out to 14 dpi, and, even at 21 dpi, infected mice showed trends toward increased lung damage relative to mock-infected mice. In all, histopathological analyses revealed that the chronic respiratory infection model results in sustained lung damage, indicative of chronic infection.</p></sec><sec id="S6"><title>InvL is a critical virulence factor for long-term infection.</title><p id="P11">The acute pulmonary infection model has been widely used to characterize <italic toggle="yes">A. baumannii</italic> virulence factors (<xref rid="R21" ref-type="bibr">21</xref>). While the acute model is valuable for identifying bacterial proteins required at early timepoints, these mice clear infection within 3&#8211;4 dpi, not allowing for the identification of factors required for prolonged infection. As a proof of principle, we sought to determine if the chronic respiratory infection model could identify proteins required for bacterial persistence in the lungs. We hypothesized that prolonged adherence to respiratory epithelium would be required for persistence, so we first tested individual mutants lacking previously identified <italic toggle="yes">A. baumannii</italic> adhesins (Bap, Ata, FhaBC, and InvL) for attenuation in the chronic infection model (<xref rid="SD1" ref-type="supplementary-material">Fig. S4</xref>) (<xref rid="R57" ref-type="bibr">57</xref>&#8211;<xref rid="R66" ref-type="bibr">66</xref>). <italic toggle="yes">tlr4</italic> mutant mice were infected with 10<sup>5</sup> G636 WT or mutant bacteria, and mice were sacrificed at 1 or 14 dpi for lung <underline>c</underline>olony-<underline>f</underline>orming <underline>u</underline>nits (CFU) quantification. This experiment indicated a possible role for InvL in long-term infection as mice began to clear bacteria in the lungs by 14 dpi. To further confirm the importance of InvL for bacterial persistence, we performed more extensive analyses with G636 WT, <italic toggle="yes">invL</italic> mutant (&#916;<italic toggle="yes">invL</italic>), and complemented <italic toggle="yes">invL</italic> mutant (<italic toggle="yes">invL</italic><sup>+</sup>) strains in the chronic infection model, sacrificing mice at 1, 7, 14, and 21 dpi to quantify CFU in the lungs (<xref rid="F4" ref-type="fig">Fig. 4A</xref>-<xref rid="F4" ref-type="fig">D</xref>). Early during infection, the &#916;<italic toggle="yes">invL</italic> mutant exhibited only a modest defect. However, at later timepoints the infection defect became more pronounced, as some mice cleared the bacteria as early as 7 dpi. By 21 dpi, all but two mice had cleared the &#916;<italic toggle="yes">invL</italic> mutant, while the majority of mice infected with the WT strain still had detectable bacteria in their lungs. Genetic complementation partially rescued this defect at these later timepoints, as no significant difference was detected between WT and complemented strains.</p><p id="P12">We next compared results from the chronic respiratory infection model to the acute infection model. We infected C57BL/6 mice with 10<sup>9</sup> G636 WT, &#916;<italic toggle="yes">invL</italic>, or <italic toggle="yes">invL</italic><sup>+</sup> strains. 24 hpi, mice were sacrificed, and CFU in the lungs, spleens, and kidneys were quantified (<xref rid="F4" ref-type="fig">Fig. 4E</xref>-<xref rid="F4" ref-type="fig">F</xref>). As opposed to results seen in the chronic infection model, the &#916;<italic toggle="yes">invL</italic> mutant had no significant defect in bacterial load in the lungs. Additionally, no defect was noted in dissemination to the spleen and kidneys, indicating that InvL is dispensable in the acute infection model. In all, these results highlight the differences in required bacterial genes between these disparate pulmonary infection models and show the importance of continuing to explore models that can better approximate clinical disease. Additionally, these experiments establish InvL as the first known <italic toggle="yes">A. baumannii</italic> virulence factor required for long-term infection.</p></sec><sec id="S7"><title>The chronic infection model can be used to study the outcome of antibiotic treatment.</title><p id="P13">The acute pulmonary infection model has been employed extensively to assess effects of antibiotic treatment (<xref rid="R21" ref-type="bibr">21</xref>). However, this model only allows us to estimate the efficacy of antibiotics by measuring the initial reduction in the bacterial burden at 24&#8211;36 hpi due to rapid bacterial clearance by the host. A clear limitation of this model is that it does not inform if bacterial infection is cleared, or if persistent bacteria remain in the lung. The chronic respiratory infection model therefore represents a novel platform that could be used to track the kinetics of <italic toggle="yes">A. baumannii</italic> clearance due to antibiotic treatment. As a proof of principle, we assessed the effect of tigecycline, colistin, and imipenem in the chronic model with strains G636 and G654 at antibiotic concentrations similar to those previously used to determine treatment efficacy in mice (<xref rid="F5" ref-type="fig">Fig. 5A</xref>-<xref rid="F5" ref-type="fig">B</xref> and <xref rid="SD1" ref-type="supplementary-material">Fig. S5A</xref>-<xref rid="SD1" ref-type="supplementary-material">D</xref>) (<xref rid="R67" ref-type="bibr">67</xref>&#8211;<xref rid="R73" ref-type="bibr">73</xref>). We additionally assessed the effect of apramycin, a drug with demonstrated efficacy and safety in mice that is currently in Phase I clinical trials for use in humans (<xref rid="F5" ref-type="fig">Fig. 5C</xref>-<xref rid="F5" ref-type="fig">D</xref>) (<xref rid="R74" ref-type="bibr">74</xref>&#8211;<xref rid="R76" ref-type="bibr">76</xref>). <underline>M</underline>inimum <underline>i</underline>nhibitory <underline>c</underline>oncentrations (MICs) for G636 and G654 for these and other commonly used antibiotics are listed in <xref rid="SD1" ref-type="supplementary-material">Table S2</xref>. Colistin was ineffective for both strains in the acute infection model, while initial reductions in CFU were noted in the chronic infection model (<xref rid="SD1" ref-type="supplementary-material">Fig. S5A</xref>-<xref rid="SD1" ref-type="supplementary-material">B</xref>). However, bacterial numbers appeared to stabilize over time in the chronic infection model, consistent with the development of bacterial persisters (discussed below). Imipenem showed limited efficacy against both strains in both models (<xref rid="SD1" ref-type="supplementary-material">Fig. S5C</xref>-<xref rid="SD1" ref-type="supplementary-material">D</xref>), as expected given the strains&#8217; resistance <italic toggle="yes">in vitro</italic> (<xref rid="SD1" ref-type="supplementary-material">Table S2</xref>). At 24 hpi, tigecycline and apramycin treatment resulted in initial reductions in CFUs in both the chronic and the acute infection models relative to PBS-treated mice (<xref rid="F5" ref-type="fig">Fig. 5A</xref>-<xref rid="F5" ref-type="fig">D</xref>). However, the chronic model enabled us to differentiate the efficacy of both antibiotics at later times. Apramycin treatment ultimately led to clearance after 3&#8211;5 days, demonstrating the efficacy of this antibiotic. However, with tigecycline treatment, although there were initial reductions in CFU, bacterial numbers leveled out over time indicative of treatment failure. The behavior of bacteria in presence of tigecycline over time is consistent with the development of persisters. Notably, the efficacy of tigecycline and apramycin against <italic toggle="yes">A. baumannii</italic> cannot be distinguished at 24 hpi. These results indicate that the chronic model can be used to determine outcome of infection with therapeutic intervention, a significant advantage over the currently employed acute infection model.</p></sec><sec id="S8"><title>Use of the chronic infection model to study bacterial co-infections reveals that Staphylococcus aureus exacerbates ongoing A. baumannii infection while Klebsiella pneumoniae leads to earlier clearance.</title><p id="P14">Approximately 25% of <italic toggle="yes">A. baumannii</italic> pulmonary infections are polymicrobial, and two of the most commonly co-infecting pathogens are <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic> (<xref rid="R9" ref-type="bibr">9</xref>). We thus sought to assess the impact of secondary infections with these two bacteria on the outcome of <italic toggle="yes">A. baumannii</italic> infection in the context of the chronic respiratory infection model. For these experiments, we first established a primary <italic toggle="yes">A. baumannii</italic> infection by inoculating <italic toggle="yes">tlr4</italic> mutant mice with 10<sup>5</sup> CFU of strain G636. Following 14 days of <italic toggle="yes">A. baumannii</italic> infection, we inoculated mice with 5 &#215; 10<sup>7</sup> CFU of <italic toggle="yes">S. aureus</italic> strain Newman or <italic toggle="yes">K. pneumoniae</italic> strain TOP52, mock-treated mice with PBS, or left mice untreated. One and two days post-secondary infection, mice were sacrificed, and bacterial CFU were quantified in the lungs, spleens, and kidneys (<xref rid="F6" ref-type="fig">Fig. 6</xref>, <xref rid="SD1" ref-type="supplementary-material">Fig. S6</xref>, and <xref rid="SD1" ref-type="supplementary-material">Fig. S7</xref>). Secondary infection with <italic toggle="yes">S. aureus</italic> led to a resurgence of <italic toggle="yes">A. baumannii</italic> CFU in the lungs of many mice, though the overall mean CFU in these mice were not significantly different from mock-infected and untreated groups (<xref rid="F6" ref-type="fig">Fig. 6A</xref> and <xref rid="F6" ref-type="fig">Fig. 6D</xref>-<xref rid="F6" ref-type="fig">E</xref>). <italic toggle="yes">A. baumannii</italic> were also identified in the spleens and kidneys of some mice that received the secondary <italic toggle="yes">S. aureus</italic> infection, even though <italic toggle="yes">A. baumannii</italic> bacteremia rarely occurs in the context of this chronic respiratory infection model (<xref rid="SD1" ref-type="supplementary-material">Fig. S6</xref>). Additionally, <italic toggle="yes">S. aureus</italic> trended toward increased numbers in the lungs, spleens, and kidneys in the context of polymicrobial infection with <italic toggle="yes">A. baumannii</italic> relative to monomicrobial infection (<xref rid="SD1" ref-type="supplementary-material">Fig. S7A</xref>-<xref rid="SD1" ref-type="supplementary-material">C</xref>). Notably, two mice succumbed to <italic toggle="yes">A. baumannii</italic>-<italic toggle="yes">S. aureus</italic> polymicrobial infection ~24 hpi following the secondary inoculation, an outcome that did not occur with monomicrobial infection with either bacterium. Contrarily, secondary infection with <italic toggle="yes">K. pneumoniae</italic> significantly decreased <italic toggle="yes">A. baumannii</italic> CFU in the lungs relative to mock-infected and untreated groups (<xref rid="F6" ref-type="fig">Fig. 6A</xref> and <xref rid="F6" ref-type="fig">Fig. 6D</xref>-<xref rid="F6" ref-type="fig">E</xref>). Additionally, polymicrobial infection with <italic toggle="yes">A. baumannii</italic> and <italic toggle="yes">K. pneumoniae</italic> resulted in significantly reduced <italic toggle="yes">K. pneumoniae</italic> CFU recovered in the lungs, spleens, and kidneys of mice relative to <italic toggle="yes">K. pneumoniae</italic> monomicrobial infection (<xref rid="SD1" ref-type="supplementary-material">Fig. S7D</xref>-<xref rid="SD1" ref-type="supplementary-material">E</xref>). Although understanding the interactions between these bacteria is beyond the scope of this work, these experiments indicate that <italic toggle="yes">S. aureus</italic> exacerbates <italic toggle="yes">A. baumannii</italic> infection, while <italic toggle="yes">K. pneumoniae</italic> attenuates infection in the context of the chronic infection model. Additionally, these results demonstrate the ability of the model to be used to study longer-term aspects of polymicrobial interactions that were not previously able to be done with the acute infection model.</p></sec></sec><sec id="S9"><title>Discussion</title><p id="P15"><italic toggle="yes">A. baumannii</italic> has emerged as a significant cause of nosocomial pneumonia and is of major clinical importance due to its extremely high rates of multidrug resistance (<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>). Despite this, our understanding of <italic toggle="yes">A. baumannii</italic> respiratory pathogenesis is hindered by a shortage of clinically relevant infection models. Here, we aimed to address this significant gap in the field by developing a novel respiratory infection model. In this pursuit, we found that, at likely more clinically-relevant inoculums, <italic toggle="yes">tlr4</italic> mutant mice maintain long-term respiratory infections by <italic toggle="yes">A. baumannii</italic>. We then demonstrate the versatility of this model which enabled i) the identification of a bacterial virulence factor required for long-term respiratory infection, which is not required in acute models, ii) the study of kinetics of bacterial clearance upon treatment with clinically-relevant antibiotics, and iii) the exploration of the impact of secondary infections with two commonly co-isolated respiratory pathogens.</p><p id="P16">In this study, we found that InvL is required for chronic infection, and, more importantly, at the later stages of infection. However, InvL was dispensable in the context of the acute infection model. There are multiple possible reasons for this discrepancy. First, the massive bacterial dose required for the acute infection model may mask potential defects that can now be detected with a smaller, more clinically-relevant inoculum. This is unlikely, as WT and <italic toggle="yes">invL</italic> mutant bacteria behave similarly at early time points in our model. An alternative reason could be that adhesins required early during infection/interaction with the healthy airway differ from those required during persistent interaction with a more inflamed or damaged airway. It is well-established that the airway <underline>e</underline>xtra<underline>c</underline>ellular <underline>m</underline>atrix (ECM) is altered by bacterial infection, lung damage, and/or inflammation (<xref rid="R91" ref-type="bibr">91</xref>, <xref rid="R92" ref-type="bibr">92</xref>). Long-term lung damage and inflammation results in increased fibronectin, collagen, laminin, and fibrinogen in the ECM (<xref rid="R93" ref-type="bibr">93</xref>&#8211;<xref rid="R98" ref-type="bibr">98</xref>). Moreover, specific pathogens elicit different inflammatory responses, resulting in distinct changes to the lung ECM. For example, in an acute mouse model of pneumonia, <italic toggle="yes">Pseudomonas aeruginosa</italic> induces versican deposition in the lungs, while <italic toggle="yes">Escherichia coli</italic> induces robust versican and hyaluronan deposition (<xref rid="R99" ref-type="bibr">99</xref>, <xref rid="R100" ref-type="bibr">100</xref>). We previously showed that InvL can bind &#945;5&#946;1 integrin, collagen V, and fibrinogen (<xref rid="R66" ref-type="bibr">66</xref>). However, whether <italic toggle="yes">A. baumannii</italic> infection or the associated inflammation induces production of these protein(s) during pulmonary infection is unknown. Future work will investigate this possibility, as well as assess which InvL-host protein interactions are essential for chronic infection.</p><p id="P17">Herein, we demonstrate the potential to use the chronic respiratory infection model to study the efficacy of antibiotic treatments over time. One intriguing finding from these experiments is that with antibiotics such as colistin and tigecycline, an initial decrease in CFU (~10&#8211;100 fold) recovered from the lungs at 1 dpi was observed. However, following this decrease, the number of bacteria in the lungs appeared to stabilize over time. It is tempting to speculate that this is the result of the formation of bacterial persisters, defined as bacterial cells that become tolerant to antibiotics despite undergoing no genetic changes (<xref rid="R101" ref-type="bibr">101</xref>&#8211;<xref rid="R103" ref-type="bibr">103</xref>). Importantly, the commonly used acute infection model does not allow for the study of bacterial persisters due to the short time course of the model. Given that persister cells represent a major cause of treatment failure and chronic infection, the chronic infection model presented here represents a unique platform that is desperately needed to understand this aspect of <italic toggle="yes">A. baumannii</italic> pathogenesis. Furthermore, our model offers new possibilities to study efficacy of novel antibiotics in murine models before committing to expensive clinical trials.</p><p id="P18">While a significant portion of <italic toggle="yes">A. baumannii</italic> infections are polymicrobial, the acute infection model has limitations for use with polymicrobial infections. First the quick clearance of the bacteria usually only allows inoculation at a single timepoint, thus not enabling investigation of secondary infections. Second, the high required infectious dose often means that typical inoculums for bacteria used in these experiments must be adjusted, so mice do not succumb to infections at early timepoints. Here, we applied the chronic respiratory infection model to assess the result of secondary infection with two pathogens commonly co-isolated with <italic toggle="yes">A. baumannii</italic>, <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">K. pneumoniae</italic>. We found opposite results with these different bacteria; <italic toggle="yes">S. aureus</italic> secondary infection trended toward exacerbation of <italic toggle="yes">A. baumannii</italic> infection, while <italic toggle="yes">K. pneumoniae</italic> secondary infection led to reduced <italic toggle="yes">A. baumannii</italic> numbers. The potential synergism of <italic toggle="yes">A. baumannii</italic> and <italic toggle="yes">S. aureus</italic> in the chronic infection model aligns with previous reports. For example, using a Tn-Seq-based approach, Li et al. demonstrated that the 49% of genes required by <italic toggle="yes">S. aureus</italic> for monomicrobial infection in a murine systemic infection model became non-essential upon <italic toggle="yes">A. baumannii</italic> co-infection (<xref rid="R104" ref-type="bibr">104</xref>). Another recent report showed that <italic toggle="yes">S. aureus</italic> can support <italic toggle="yes">A. baumannii</italic> growth <italic toggle="yes">in vitro</italic> by providing acetoin as a carbon source (<xref rid="R105" ref-type="bibr">105</xref>).</p><p id="P19">Although we found that <italic toggle="yes">K. pneumoniae</italic> secondary infection led to reduced <italic toggle="yes">A. baumannii</italic> numbers in the lungs in the chronic infection model, one study has shown that <italic toggle="yes">K. pneumoniae</italic> could cross-feed <italic toggle="yes">A. baumannii</italic> through products of sugar fermentation <italic toggle="yes">in vitro</italic> and demonstrated that co-infection led to reduced survival of <italic toggle="yes">Galleria mellonella</italic> relative to monomicrobial infection with either pathogen (<xref rid="R106" ref-type="bibr">106</xref>). This, in part, shows that these two bacteria can have beneficial interactions. There are two potential reasons however for the reduction of CFU for both bacteria in the context of the chronic infection model reported here; i) bacterial competition or ii) the host response to the secondary infection. Regarding bacterial competition, there have been several lines of evidence pointing to direct bacterial killing between diverse <italic toggle="yes">A. baumannii</italic> and <italic toggle="yes">K. pneumoniae</italic> strains mediated by the type VI secretion system (<xref rid="R107" ref-type="bibr">107</xref>&#8211;<xref rid="R110" ref-type="bibr">110</xref>). In addition to direct killing, this bacterial competition could be indirect as well, as both <italic toggle="yes">A. baumannii</italic> and <italic toggle="yes">K. pneumoniae</italic> may be competing for similar nutrients in the lung microenvironment. With respect to the immune response, a difference between this work and the above study is that the microenvironment encountered in the mammalian lung is not perfectly modeled by the wax moth (<xref rid="R111" ref-type="bibr">111</xref>). Our results may therefore be the result of TLR4-independent host response elicited by the combination of both bacteria that is not recapitulated by a <italic toggle="yes">G. mellonella</italic> model. While understanding the precise mechanism behind the <italic toggle="yes">in vivo</italic> interactions between <italic toggle="yes">A. baumannii</italic> and commonly co-isolated pathogens is outside the scope of the current study, these results highlight the practicality of applying the chronic respiratory infection model to better understand polymicrobial infections.</p><p id="P20">In this study, we have validated several different uses for the chronic respiratory infection model. However, there are also other potential uses for this model that were not previously investigable. For example, we can now perform experiments differentiating between virulence factors required for establishment of infection and factors required for maintenance of infection, assessing bacterial evolution during long-term infection, investigating changes in the pulmonary microbiome due to infection over time, and analyzing the long-term outcomes of novel therapies such as newly developed phage cocktails. Additionally, while this model was initially developed to study <italic toggle="yes">Acinetobacter</italic> respiratory infections, it has the potential to be applied to research with other respiratory pathogens in cases where suitable animal models are lacking. In all, this work describes the longest-term infection model available to investigate <italic toggle="yes">A. baumannii</italic> host-pathogen interactions to date, which will ultimately aid in the development of novel therapeutics to combat infection by this increasingly multidrug-resistant bacterium.</p></sec><sec id="S10"><title>Materials and Methods</title><sec id="S11"><title>Bacterial plasmids, strains, and growth conditions.</title><p id="P21">Plasmids and strains used in this study are detailed in <xref rid="SD1" ref-type="supplementary-material">Table S3</xref>. Bacterial cultures were grown at 37&#176;C in Lennox broth/agar supplemented with 10 &#956;g/mL chloramphenicol, 50 &#956;g/mL apramycin, 100 &#956;g/mL ampicillin, 50 &#956;g/mL kanamycin, 10 &#956;g/mL tetracycline, or 10% sucrose when appropriate.</p></sec><sec id="S12"><title>Murine pneumonia models.</title><p id="P22">All animal experiments were approved by the Washington University Animal Care and Use Committee, and we have complied with all relevant ethical regulations. The acute pneumonia model was performed similar to previously described experiments (<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R112" ref-type="bibr">112</xref>). Briefly, overnight cultures were subcultured at a 1:200 dilution and grown shaking at 37&#176;C for 3 h to mid-exponential growth phase. Six- to eight-week-old female C57BL/6 mice (Charles River Laboratories, Wilmington, MA) anesthetized with 4% isoflurane were intranasally inoculated with 10<sup>9</sup> CFU that were twice-washed in PBS. At 24 hpi, mice were sacrificed, and CFU in the lungs, spleen, and kidneys were quantified by serial dilution plating the homogenized organs. For experiments with C3H/HeN (Envigo International Holdings, Indianapolis, IN) and C3H/HeJ (Jackson Laboratory, Bar Harbor, ME) mice, <italic toggle="yes">A. baumannii</italic>, <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">K. pneumoniae</italic> inoculums were prepared and mice were intranasally inoculated as described above, with the exception that inoculums of 10<sup>5</sup> and 10<sup>8</sup> CFU were used for <italic toggle="yes">A. baumannii</italic>, and 5 &#215; 10<sup>7</sup> CFU was used for <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">K. pneumoniae</italic>. Following, at the indicated timepoints, mice were sacrificed and bacteria in the lungs, spleen, and kidneys were quantified as described above. For co-infections, <italic toggle="yes">A. baumannii</italic> was distinguished from <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">K. pneumoniae</italic> by plating on LB agar supplemented with 10 &#956;g/mL chloramphenicol. For antibiotic treatment experiments the indicated mice were treated intraperitoneally with PBS or 100 mg/kg tigecycline every 12 h, PBS or 5 mg/kg colistin every 8 h, PBS or 500 mg/kg apramycin every 12 h, or PBS or 100 mg/kg imipenem every 12 h with all treatments beginning 4 hpi. Antibiotics for intraperitoneal treatments were dissolved in PBS, and the injection volume was 100 &#956;l.</p></sec><sec id="S13"><title>Flow cytometry.</title><p id="P23">Flow cytometry was performed similarly to previously described <xref rid="S10" ref-type="sec">methods</xref> (<xref rid="R31" ref-type="bibr">31</xref>). Briefly, BALF samples were collected in PBS supplemented with 1 mM EDTA, and cells were collected by centrifugation at 300 x <italic toggle="yes">g</italic> for 5 min. Cells were then resuspended in Pharm Lyse Buffer (BD Biosciences, Franklin Lakes, NJ) and incubated for 3 min at room temperature to lyse red blood cells. Cells were subsequently washed in <underline>f</underline>luorescence-<underline>a</underline>ctivated <underline>c</underline>ell <underline>s</underline>orting (FACS) buffer (PBS supplemented with 1% heat inactivated fetal bovine serum and 0.1% sodium azide) and blocked with TruStain FcX PLUS (BioLegend, San Diego, CA) for 15 min at 4&#176;C. Samples were then stained with anti-CD45-BV605 (BioLegend), anti-CD11c-APC (BioLegend), anti-SiglecF-PerCP5.5 (BioLegend), and anti-Ly6G-BV421 (Biolegend) for 30 min at 4&#176;C. Following, cells were washed in FACS buffer and fixed in 2% <underline>p</underline>ara<underline>f</underline>orm<underline>a</underline>ldehyde (PFA). Samples were read on a LSR II Fortessa cytometer (BD Biosciences) or an Aurora cytometer (Cytek Biosciences, Fremont, CA). Total cell counts in the BALF were calculated using Precision Count Beads (BioLegend) according to the manufacturer&#8217;s instructions.</p></sec><sec id="S14"><title>Antibiotic protection assays.</title><p id="P24">Antibiotic protection assays were performed as previously described (<xref rid="R31" ref-type="bibr">31</xref>). To determine the number of total and intracellular bacteria present in BALF from <italic toggle="yes">A</italic>. <italic toggle="yes">baumannii</italic> infected mice, two 500 &#956;l aliquots of lavage fluid were centrifuged at 4100 x <italic toggle="yes">g</italic> for 5 min. Pelleted cells were resuspended in warm <underline>D</underline>ulbecco&#8217;s <underline>M</underline>odified <underline>E</underline>agle <underline>M</underline>edium (DMEM) (total bacteria) or DMEM with colistin (50 &#956;g/mL) (intracellular bacteria) and incubated for 1h at 37&#176;C. Samples were then washed three times with PBS and lysed with 500 &#956;L of Triton X-100 (0.05%). CFUs were determined by serial dilutions of the bacterial suspensions. The remaining lungs following BALF collection were also homogenized, and CFUs were quantified by serial dilution plating.</p></sec><sec id="S15"><title>Cytospin of BALF cells.</title><p id="P25">Cytospin of BALF cells was performed similar to previously described work (<xref rid="R31" ref-type="bibr">31</xref>). BALF samples were centrifugated at 300 x <italic toggle="yes">g</italic> for 5 min, and the pellets were resuspended in 1 mL Pharm Lyse Buffer (BD Biosciences) and incubated for 5 min on ice to lyse red blood cells. 9 mL of PBS was added to stop the lysis, viability was determined using Trypan Blue solution (Sigma-Aldrich, St. Louis, MO), and cells were counted using the TC20 Automated Cell Counter (Bio-Rad Laboratories, Hercules, CA). Samples were centrifugated at 300 x <italic toggle="yes">g</italic> for 6 min onto CytoPro Poly-L-Lysine Coated Microscope Slides (ELITechGroup Inc., Logan, UT) using a Cytospin Cytocentrifugue (Fisher Scientific, Hampton, NH). The slides were air-dried overnight at 4&#176;C and fixed in 4% PFA for 30 min at room temperature. Samples were incubated with permeabilizing and blocking solution (PBS supplemented with 0.1% saponin, 0.5% bovine serum albumin, and 10% heat inactivated fetal bovine serum). Cells were stained with Alexa Fluor 555 Phalloidin (Cell Signaling Technology, Danvers, MA) and 4&#8217;,6-<underline>D</underline>i<underline>a</underline>midino-2-<underline>p</underline>henyl<underline>i</underline>ndole dihydrochloride (DAPI) solution (Invitrogen) for 1 h at 37&#176;C. After staining, the samples were rinsed with washing solution [PBS supplemented with 0.1% saponin and 0.5% <underline>b</underline>ovine <underline>s</underline>erum <underline>a</underline>lbumin (BSA)], and then rinsed with water and mounted on a coverslip in ProLong Gold Antifade Mountant (Invitrogen).</p></sec><sec id="S16"><title>Confocal microscopy.</title><p id="P26">Confocal microscopy was performed as previously described (<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R66" ref-type="bibr">66</xref>). Microscopy slides were analyzed with a Zeiss LSM880 laser scanning confocal microscope (Carl Zeiss AG, Oberkochen, Germany) equipped with 405nm diode, 488nm Argon, 543nm HeNe, and 633nm HeNe lasers. A Plan-Apochromat 63X DIC objective and ZEN black 2.1 SP3 software were used for image acquisition. Images were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD) (<xref rid="R113" ref-type="bibr">113</xref>).</p></sec><sec id="S17"><title>Cytokine analysis.</title><p id="P27">BALF was collected and centrifuged at 300 x <italic toggle="yes">g</italic> for 5 min. Supernatant containing cytokines was then collected and frozen at &#8722;20&#176;C until the analysis was performed. Cytokine levels were determined using the LEGENDplex Mouse Inflammation Panel (13-plex) with V-bottom Plate (BioLegend) according to the manufacturer&#8217;s instructions. Samples were read using an Aurora cytometer (Cytek Biosciences).</p></sec><sec id="S18"><title>Histopathology of lung slices.</title><p id="P28">Lung slices were prepared, stained, and scored as previously described by Castro et al. (<xref rid="R71" ref-type="bibr">71</xref>). Briefly, lungs were perfused with PBS, inflated with <underline>o</underline>ptimal <underline>c</underline>utting <underline>t</underline>emperature (OCT) compound (Fisher Scientific) diluted in 4% PFA at a 1:1 ratio, snap-frozen, and stored at &#8722;80&#176;C until sectioning. For histology imaging, 4 &#956;m tissue sections were stained with H&amp;E and imaged with a ZEISS Axioscan 7 Microscope Slide Scanner (Carl Zeiss AG). Lung tissues were blindly scored on a scale of 0 to 3 for alveolitis, peribronchiolitis, smooth muscle hypertrophy, squamous epithelium metaplasia, BALT formation, goblet cell hyperplasia, and fibrosis. Area affected was quantified, multiplied by previously defined intensity scores, and the resulting weighted scores are reported.</p></sec><sec id="S19"><title>Generation of constructs and strains used in this study.</title><p id="P29">Primers used in this study are listed in <xref rid="SD1" ref-type="supplementary-material">Table S4</xref>. DNA fragments were assembled using either the In-Fusion HD EcoDry Cloning Kit (TaKaRa Bio, Mountain View, CA) or NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs, Ipswich, MA). To generate the vector for generation of the <italic toggle="yes">invL</italic> mutational construct, pEX18Tc was amplified without the tetracycline resistance cassette (primers: 5&#8217; pEX18 marker swap and 3&#8217; pEX18 marker swap), the apramycin resistance cassette was amplified from pKD4-Apr (primers: 5&#8217; Apr for pEX18Ap and 3&#8217; Apr for pEX18Ap), and the amplicons were assembled, generating pEX18Ap (<xref rid="R114" ref-type="bibr">114</xref>, <xref rid="R115" ref-type="bibr">115</xref>). The pEX18Ap mutational constructs were then made by amplifying the pEX18Ap vector (primers: 5&#8217; pEX18Tc and 3&#8217; pEX18Tc), a ~1000 bp region upstream of the genes of interest (<italic toggle="yes">invL</italic>KO primers: 5&#8217; F1 G636 <italic toggle="yes">invL</italic>KO and 3&#8217; F1 G636 <italic toggle="yes">invL</italic>KO; <italic toggle="yes">bap</italic>KO primers: 5&#8217; F1 G636 <italic toggle="yes">bap</italic>KO and 3&#8217; F1 G636 <italic toggle="yes">bap</italic>KO; <italic toggle="yes">ata</italic>KO primers: 5&#8217; F1 G636 <italic toggle="yes">ata</italic>KO and 3&#8217; F1 G636 <italic toggle="yes">ata</italic>KO; <italic toggle="yes">fhaBC</italic>KO primers: 5&#8217; F1 G636 <italic toggle="yes">fhaBC</italic>KO and 3&#8217; F1 G636 <italic toggle="yes">fhaBC</italic>KO), and a ~1000 bp region downstream of the genes of interest (<italic toggle="yes">invL</italic>KO primers: 5&#8217; F2 G636 <italic toggle="yes">invL</italic>KO and 3&#8217; F2 G636 <italic toggle="yes">invL</italic>KO; <italic toggle="yes">bap</italic>KO primers: 5&#8217; F2 G636 <italic toggle="yes">bap</italic>KO and 3&#8217; F2 G636 <italic toggle="yes">bap</italic>KO; <italic toggle="yes">ata</italic>KO primers: 5&#8217; F2 G636 <italic toggle="yes">ata</italic>KO and 3&#8217; F2 G636 <italic toggle="yes">ata</italic>KO; <italic toggle="yes">fhaBC</italic>KO primers: 5&#8217; F2 G636 <italic toggle="yes">fhaBC</italic>KO and 3&#8217; F2 G636 <italic toggle="yes">fhaBC</italic>KO), followed by assembly of these amplicons. Mutational constructs were then transformed into G636, and strains with the integrated plasmid were selected for by apramycin treatment. Counterselection for double crossover was performed by plating these strains on LB agar without NaCl supplemented with 10% sucrose. Mutants were then confirmed by PCR analyses and whole-genome sequencing.</p><p id="P30">The <italic toggle="yes">invL</italic> complementation construct was generated by amplifying the putative promoter region (~300 bp upstream) along with the <italic toggle="yes">invL</italic> open reading frame (primers: 5&#8217; G636 <italic toggle="yes">fdeC</italic>KO Comp and 3&#8217; G636 <italic toggle="yes">fdeC</italic>KO Comp-His6 v2) and the pUC18T-miniTn7T-Apr vector (primers: Tn7 linear Fwd-His6 and Tn7 liner Rev) (<xref rid="R116" ref-type="bibr">116</xref>). These amplicons were then assembled, generating pUC18T-miniTn7T-Apr::G636 <italic toggle="yes">invL</italic>KO comp. To generate the <italic toggle="yes">gfp</italic> integration construct, the <italic toggle="yes">gfp</italic> cassette was amplified from PB-FLuc+GFPd2 (primers: 5&#8217; d2EGFP for pUC18T-mTn7 and 3&#8217; d2EGFP for pUC18T-mTn7) and pUC18T-mTn7-Apr was amplified (primers: 5&#8217; pUC18T-mTn7 for d2EGFP and 3&#8217; pUC18T-mTn7 for d2EGFP). These fragments were then assembled, generating pUC18T-miniTn7T-Apr::<italic toggle="yes">gfpd2</italic>. pUC18T-miniTn7T-Apr::G636 <italic toggle="yes">invL</italic>KO comp and pUC18T-miniTn7T-Apr::<italic toggle="yes">gfpd2</italic> were introduced into G636 &#916;<italic toggle="yes">invL</italic> and G636, respectively, using a four-parental conjugation technique, as previously described (<xref rid="R116" ref-type="bibr">116</xref>&#8211;<xref rid="R119" ref-type="bibr">119</xref>). Selection was achieved using LB supplemented with apramycin and chloramphenicol, and insertion of the respective fragments at the mTn7 site in the resulting G636 <italic toggle="yes">invL</italic><sup>+</sup> and G636-<italic toggle="yes">gfp</italic> strains was confirmed by PCR analyses.</p></sec><sec id="S20"><title>Antibiotic susceptibility assays.</title><p id="P31">MIC analyses were performed using a two-fold broth dilution microtiter assay similar to previously described protocols (<xref rid="R112" ref-type="bibr">112</xref>, <xref rid="R120" ref-type="bibr">120</xref>, <xref rid="R121" ref-type="bibr">121</xref>). Briefly, overnight cultures were sub-cultured at 0.05 Abs<sub>600</sub> and grown for 3 h shaking at 37 hpi. Mid-exponential growth phase cultures were then inoculated at 0.01 Abs<sub>600</sub> into a 96-well microtiter plate (Corning Inc, Corning, NY) containing two-fold decreasing dilutions of the indicated antibiotics. Plates were then incubated at 37&#176;C with shaking for 24 h. The MIC was defined as less than 10% of the Abs<sub>600</sub> of an untreated control.</p></sec><sec id="S21"><title>Statistical methods.</title><p id="P32">All statistical analyses were performed using GraphPad Prism version 9, and <italic toggle="yes">P</italic> values of &lt;0.05 were considered statistically significant. When normally distributed, data sets were analyzed with Unpaired Student&#8217;s <italic toggle="yes">t</italic>-tests (comparing two samples), one-way <underline>an</underline>alysis <underline>o</underline>f <underline>va</underline>riance (ANOVA) with Tukey&#8217;s test for multiple comparisons (comparing more than two samples), or two-way ANOVA with Tukey&#8217;s test for multiple comparisons (comparing more than two samples with two independent variables). For non-normally distributed data sets, the Mann-Whitney <italic toggle="yes">U</italic> test (comparing two samples) or the Kruskal Wallis <italic toggle="yes">H</italic> test with Dunn&#8217;s test for multiple comparisons (comparing more than two samples) was used.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><label>Supplement 1</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHPP2024.09.17.613469v2-supplement-1.pdf" id="d67e1572" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements</title><p id="P33">This work was supported by funding to M.F.F. (R01AI166359 - CHECK), C.J.L. (T32AI007172), and C.B.L (R01AI137062) through the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. JM was supported through The American Association of Immunologists Careers in Immunology Fellowship Program and The Pediatric Cardiovascular and Pulmonary Research Training Program (5T32HL125241-07). The modern respiratory isolates used in this study, G636 (strain 3689) and G654 (strain 6919), were collected by the CDC-funded Georgia <underline>E</underline>merging <underline>I</underline>nfections <underline>P</underline>rogram&#8217;s (EIP) <underline>Mu</underline>lti-site <underline>G</underline>ram-Negative <underline>S</underline>urveillance <underline>I</underline>nitiative (MuGSI) and kindly provided by Sarah Satola. We also acknowledge Jennifer Philips, Jacco Boon, and Gayan Bamunuarachchi for thoughtful discussion about the manuscript. We thank Wandy Beatty and the Washington University School of Medicine Molecular Microbiology Imaging Facility for microscopy assistance, Alma Johnson of the Washington University Center for Reproductive Health Sciences Histocore for lung tissue slide mounting and staining assistance, and De Chen of the Washington University Center for Cellular Imaging for assistance with the Zeiss AxioScan Z1. Finally, we thank Dakota Hall for technical assistance with experiments.</p></ack><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vijayakumar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Biswas</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Veeraraghavan</surname><given-names>B</given-names></name>. <year>2019</year>. <article-title>Accurate identification of clinically important Acinetobacter spp.: an update</article-title>. <source>Future Sci OA</source><volume>5</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2144/fsoa-2018-0127</pub-id><pub-id pub-id-type="pmcid">PMC6609899</pub-id><pub-id pub-id-type="pmid">31285840</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cerqueira</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Peleg</surname><given-names>AY</given-names></name>. <year>2011</year>. <article-title>Insights into Acinetobacter baumannii pathogenicity</article-title>. <source>IUBMB Life</source><volume>63</volume>:<fpage>1055</fpage>&#8211;<lpage>1060</lpage>.<pub-id pub-id-type="pmid">21989983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iub.533</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sarshar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Behzadi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Scribano</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Palamara</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Ambrosi</surname><given-names>C</given-names></name>. <year>2021</year>. <article-title>Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen</article-title>. <source>Pathogens</source><volume>10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pathogens10040387</pub-id><pub-id pub-id-type="pmcid">PMC8063835</pub-id><pub-id pub-id-type="pmid">33804894</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Flores-Mireles</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Calix</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Haurat</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Potter</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Hibbing</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dantas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Skaar</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Hultgren</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2019</year>. <article-title>Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes</article-title>. <source>Nat Commun</source><volume>10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-10706-y</pub-id><pub-id pub-id-type="pmcid">PMC6591400</pub-id><pub-id pub-id-type="pmid">31235751</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Murray</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Ikuta</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Sharara</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Swetschinski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Robles Aguilar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bisignano</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wool</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Browne</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Chipeta</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Fell</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hackett</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haines-Woodhouse</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Kashef Hamadani</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Kumaran</surname><given-names>EAP</given-names></name>, <name name-style="western"><surname>McManigal</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Agarwal</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Akech</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Albertson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Amuasi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Aravkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ashley</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bailey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Basnyat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bekker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bender</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bethou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bielicki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Boonkasidecha</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bukosia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Carvalheiro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Casta&#241;eda-Orjuela</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chansamouth</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Chaurasia</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chiurchi&#249;</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chowdhury</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cressey</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Criollo-Mora</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Darboe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>NPJ</given-names></name>, <name name-style="western"><surname>De Luca</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dokova</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dramowski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dunachie</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Eckmanns</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Eibach</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Emami</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Feasey</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fisher-Pearson</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Forrest</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Garrett</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gastmeier</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Giref</surname><given-names>AZ</given-names></name>, <name name-style="western"><surname>Greer</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Haller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haselbeck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Holm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iregbu</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jarovsky</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Javanmardi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Khorana</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kissoon</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kobeissi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kostyanev</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Krapp</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Krumkamp</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kyu</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Limmathurotsakul</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Loftus</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lunn</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mturi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Munera-Huertas</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Musicha</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mussi-Pinhata</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nanavati</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nangia</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ngoun</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Novotney</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nwakanma</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Obiero</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Olivas-Martinez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Olliaro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ooko</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ortiz-Brizuela</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Peleg</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Perrone</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Plakkal</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ponce-de-Leon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Raad</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ramdin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Riddell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Robotham</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Roca</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rudd</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schnall</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>JAG</given-names></name>, <name name-style="western"><surname>Shivamallappa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sifuentes-Osornio</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Steenkeste</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Stewardson</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Stoeva</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tasak</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thaiprakong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thwaites</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>P</given-names></name>, <name name-style="western"><surname>van Doorn</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Velaphi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vongpradith</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Waner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wangrangsimakul</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wozniak</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sartorius</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Stergachis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dolecek</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Naghavi</surname><given-names>M</given-names></name>. <year>2022</year>. <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>The Lancet</source><volume>399</volume>:<fpage>629</fpage>&#8211;<lpage>655</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmcid">PMC8841637</pub-id><pub-id pub-id-type="pmid">35065702</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dexter</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Paulsen</surname><given-names>IT</given-names></name>, <name name-style="western"><surname>Peleg</surname><given-names>AY</given-names></name>. <year>2015</year>. <article-title>Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis</article-title>. <source>Expert Rev Anti Infect Ther</source><volume>13</volume>:<fpage>567</fpage>&#8211;<lpage>573</lpage>.<pub-id pub-id-type="pmid">25850806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1586/14787210.2015.1025055</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cisneros</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rodriguez-Ba&#241;o</surname><given-names>J</given-names></name>. <year>2002</year>. <article-title>Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment</article-title>. <source>Clin Microbiol Infect</source><volume>8</volume>:<fpage>687</fpage>&#8211;<lpage>693</lpage>.<pub-id pub-id-type="pmid">12445005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1469-0691.2002.00487.x</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ibrahim</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al-Saryi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Al-Kadmy</surname><given-names>IMS</given-names></name>, <name name-style="western"><surname>Aziz</surname><given-names>SN</given-names></name>. <year>2021</year>. <article-title>Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals</article-title>. <source>Mol Biol Rep</source><volume>48</volume>:<fpage>6987</fpage>&#8211;<lpage>6998</lpage>.<pub-id pub-id-type="pmid">34460060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11033-021-06690-6</pub-id><pub-id pub-id-type="pmcid">PMC8403534</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Karakonstantis</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kritsotakis</surname><given-names>EI</given-names></name>. <year>2021</year>. <article-title>Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex</article-title>. <source>Infection</source><volume>49</volume>:<fpage>1149</fpage>&#8211;<lpage>1161</lpage>.<pub-id pub-id-type="pmid">34260054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s15010-021-01663-0</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xiao</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>X</given-names></name>. <year>2017</year>. <article-title>Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis</article-title>. <source>Exp Ther Med</source><volume>13</volume>:<fpage>1630</fpage>&#8211;<lpage>1633</lpage>.<pub-id pub-id-type="pmid">28413520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/etm.2017.4137</pub-id><pub-id pub-id-type="pmcid">PMC5377569</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sengstock</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Thyagarajan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Apalara</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mira</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chopra</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kaye</surname><given-names>KS</given-names></name>. <year>2010</year>. <article-title>Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes</article-title>. <source>Clin Infect Dis</source><volume>50</volume>:<fpage>1611</fpage>&#8211;<lpage>1616</lpage>.<pub-id pub-id-type="pmid">20462357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/652759</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Inchai</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pothirat</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bumroongkit</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Limsukon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Khositsakulchai</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liwsrisakun</surname><given-names>C</given-names></name>. <year>2015</year>. <article-title>Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia</article-title>. <source>J Intensive Care</source><volume>3</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40560-015-0077-4</pub-id><pub-id pub-id-type="pmcid">PMC4940762</pub-id><pub-id pub-id-type="pmid">27408726</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Giammanco</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cal&#224;</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fasciana</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dowzicky</surname><given-names>MJ</given-names></name>. <year>2017</year>. <article-title>Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial</article-title>. <source>mSphere</source><volume>2</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mSphere.00310-16</pub-id><pub-id pub-id-type="pmcid">PMC5244261</pub-id><pub-id pub-id-type="pmid">28124025</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tacconelli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carrara</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Savoldi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kattula</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Burkert</surname><given-names>F</given-names></name>. <year>2018</year>. <article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title>. <source>Lancet Infect Dis</source><volume>18</volume>:<fpage>318</fpage>&#8211;<lpage>327</lpage>.<pub-id pub-id-type="pmid">29276051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(17)30753-3</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kollef</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shorr</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Martin-Loeches</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Micek</surname><given-names>ST</given-names></name>. <year>2021</year>. <article-title>Nosocomial Infection</article-title>. <source>Crit Care Med</source><volume>49</volume>:<fpage>169</fpage>&#8211;<lpage>187</lpage>.<pub-id pub-id-type="pmid">33438970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CCM.0000000000004783</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jones</surname><given-names>RN</given-names></name>. <year>2010</year>. <article-title>Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia</article-title>. <source>Clin Infect Dis</source><volume>51</volume><issue>Suppl 1</issue>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/653053</pub-id><pub-id pub-id-type="pmid">20597676</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sader</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Castanheira</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mendes</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Flamm</surname><given-names>RK</given-names></name>. <year>2018</year>. <article-title>Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015&#8211;17)</article-title>. <source>J Antimicrob Chemother</source><volume>73</volume>:<fpage>3053</fpage>&#8211;<lpage>3059</lpage>.<pub-id pub-id-type="pmid">30060117</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dky279</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weber</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Harding</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2015</year>. <article-title>Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond</article-title>. <source>J Bacteriol</source><volume>198</volume>:<fpage>880</fpage>&#8211;<lpage>887</lpage>.<pub-id pub-id-type="pmid">26712938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.00906-15</pub-id><pub-id pub-id-type="pmcid">PMC4772598</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kebaier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chamberland</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Broglie</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Jania</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Doerschuk</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tilley</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>JA</given-names></name>. <year>2012</year>. <article-title>Staphylococcus aureus &#945;-Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome</article-title>. <source>J Infect Dis</source><volume>205</volume>:<fpage>807</fpage>&#8211;<lpage>817</lpage>.<pub-id pub-id-type="pmid">22279123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jir846</pub-id><pub-id pub-id-type="pmcid">PMC3274379</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoffmann</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Rasmussen</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>P&#216;</given-names></name>, <name name-style="western"><surname>Stub</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hentzer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Molin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ciofu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Givskov</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Johansen</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>H&#248;iby</surname><given-names>N</given-names></name>. <year>2005</year>. <article-title>Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis</article-title>. <source>Infect Immun</source><volume>73</volume>:<fpage>2504</fpage>.<pub-id pub-id-type="pmid">15784597</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.73.4.2504-2514.2005</pub-id><pub-id pub-id-type="pmcid">PMC1087399</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Palmer</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Green</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Sheldon</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Skaar</surname><given-names>EP</given-names></name>. <year>2019</year>. <article-title>Assessing Acinetobacter baumannii Virulence and Persistence in a Murine Model of Lung Infection</article-title>. <source>Methods Mol Biol</source><volume>1946</volume>:<fpage>289</fpage>&#8211;<lpage>305</lpage>.<pub-id pub-id-type="pmid">30798564</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4939-9118-1_26</pub-id><pub-id pub-id-type="pmcid">PMC6446551</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pogue</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kanakamedala</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>B</given-names></name>. <year>2022</year>. <article-title>Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019</article-title>. <source>BMC Infect Dis</source><volume>22</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12879-021-07024-4</pub-id><pub-id pub-id-type="pmcid">PMC8740340</pub-id><pub-id pub-id-type="pmid">34991499</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Alotaibi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Abuhaimed</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alshahrani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Albdelhady</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Almubarak</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Almasari</surname><given-names>O</given-names></name>. <year>2021</year>. <article-title>Prevalence of multidrug-resistant Acinetobacter baumannii in a critical care setting: A tertiary teaching hospital experience</article-title>. <source>SAGE Open Med</source><volume>9</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/20503121211001144</pub-id><pub-id pub-id-type="pmcid">PMC7968016</pub-id><pub-id pub-id-type="pmid">33796296</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Koomanachai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nicolau</surname><given-names>DP</given-names></name>. <year>2009</year>. <article-title>Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model</article-title>. <source>Journal of Antimicrobial Chemotherapy</source><volume>63</volume>:<fpage>982</fpage>&#8211;<lpage>987</lpage>.<pub-id pub-id-type="pmid">19279050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkp056</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Koomanachai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nicolau</surname><given-names>DP</given-names></name>. <year>2009</year>. <article-title>Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model</article-title>. <source>Journal of Antimicrobial Chemotherapy</source><volume>63</volume>:<fpage>982</fpage>&#8211;<lpage>987</lpage>.<pub-id pub-id-type="pmid">19279050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkp056</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Crandon</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nicolau</surname><given-names>DP</given-names></name>. <year>2009</year>. <article-title>Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs</article-title>. <source>Journal of Antimicrobial Chemotherapy</source><volume>64</volume>:<fpage>837</fpage>&#8211;<lpage>839</lpage>.<pub-id pub-id-type="pmid">19696049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkp301</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Braunstein</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Papo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shai</surname><given-names>Y</given-names></name>. <year>2004</year>. <article-title>In Vitro Activity and Potency of an Intravenously Injected Antimicrobial Peptide and Its dl Amino Acid Analog in Mice Infected with Bacteria</article-title>. <source>Antimicrob Agents Chemother</source><volume>48</volume>:<fpage>3127</fpage>.<pub-id pub-id-type="pmid">15273131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.48.8.3127-3129.2004</pub-id><pub-id pub-id-type="pmcid">PMC478488</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Joly-Guillou</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pocidalo</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Carbon</surname><given-names>C</given-names></name>. <year>1997</year>. <article-title>Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem</article-title>. <source>Antimicrob Agents Chemother</source><volume>41</volume>:<fpage>345</fpage>.<pub-id pub-id-type="pmid">9021190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.41.2.345</pub-id><pub-id pub-id-type="pmcid">PMC163712</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Song</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>WJ</given-names></name>. <year>2009</year>. <article-title>Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model</article-title>. <source>Int J Antimicrob Agents</source><volume>33</volume>:<fpage>33</fpage>&#8211;<lpage>39</lpage>.<pub-id pub-id-type="pmid">18835761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijantimicag.2008.07.008</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Manepalli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gandhi</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ekhar</surname><given-names>V V</given-names></name>., <name name-style="western"><surname>Asplund</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Coelho</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>LR</given-names></name>. <year>2013</year>. <article-title>Characterization of a cyclophosphamide-induced murine model of immunosuppression to study Acinetobacter baumannii pathogenesis</article-title>. <source>J Med Microbiol</source><volume>62</volume>:<fpage>1747</fpage>&#8211;<lpage>1754</lpage>.<pub-id pub-id-type="pmid">24000227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/jmm.0.060004-0</pub-id><pub-id pub-id-type="pmcid">PMC4083505</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Distel</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mackel</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2023</year>. <article-title>Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH</article-title>. <source>PLoS Pathog</source><volume>19</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1011173</pub-id><pub-id pub-id-type="pmcid">PMC10286980</pub-id><pub-id pub-id-type="pmid">37294840</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sycz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Distel</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Sartorio</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Beatty</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2021</year>. <article-title>Modern Acinetobacter baumannii clinical isolates replicate inside spacious vacuoles and egress from macrophages</article-title>. <source>PLoS Pathog</source><volume>17</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1009802</pub-id><pub-id pub-id-type="pmcid">PMC8376066</pub-id><pub-id pub-id-type="pmid">34370792</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Valcek</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Philippe</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Whiteway</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Robino</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Nesporova</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bov&#233;</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Coenye</surname><given-names>T</given-names></name>, <name name-style="western"><surname>De Pooter</surname><given-names>T</given-names></name>, <name name-style="western"><surname>De Coster</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Strazisar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Van der Henst</surname><given-names>C</given-names></name>. <year>2023</year>. <article-title>Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii</article-title>. <source>Microbiol Spectr</source><volume>11</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.03061-22</pub-id><pub-id pub-id-type="pmcid">PMC9927488</pub-id><pub-id pub-id-type="pmid">36475894</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rubio</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gagn&#233;</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Debruyne</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dias</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cluzel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mongellaz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rousselle</surname><given-names>P</given-names></name>, <name name-style="western"><surname>G&#246;ttig</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Seifert</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Higgins</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Salcedo</surname><given-names>SP</given-names></name>. <year>2022</year>. <article-title>Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates</article-title>. <source>mSystems</source><volume>7</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/msystems.00488-21</pub-id><pub-id pub-id-type="pmcid">PMC8805633</pub-id><pub-id pub-id-type="pmid">35103489</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sato</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Unno</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miyazaki</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ubagai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ono</surname><given-names>Y</given-names></name>. <year>2019</year>. <article-title>Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages</article-title>. <source>Sci Rep</source><volume>9</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-53846-3</pub-id><pub-id pub-id-type="pmcid">PMC6877552</pub-id><pub-id pub-id-type="pmid">31767923</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cochet</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Peri</surname><given-names>F</given-names></name>. <year>2017</year>. <article-title>The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling</article-title>. <source>Int J Mol Sci</source><volume>18</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms18112318</pub-id><pub-id pub-id-type="pmcid">PMC5713287</pub-id><pub-id pub-id-type="pmid">29099761</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></name>. <year>2010</year>. <article-title>Lipid A receptor TLR4-mediated signaling pathways</article-title>. <source>Adv Exp Med Biol</source><volume>667</volume>:<fpage>59</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="pmid">20665200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4419-1603-7_6</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Homma</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Matsuura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kanegasaki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kawakubo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kojima</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shibukawa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kumazawa</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tanamoto</surname><given-names>K ichi</given-names></name>, <name name-style="western"><surname>Yasuda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Imoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kusumoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shiba</surname><given-names>T</given-names></name>. <year>1985</year>. <article-title>Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues</article-title>. <source>J Biochem</source><volume>98</volume>:<fpage>395</fpage>&#8211;<lpage>406</lpage>.<pub-id pub-id-type="pmid">4066647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/oxfordjournals.jbchem.a135294</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kawasaki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>T</given-names></name>. <year>2014</year>. <article-title>Toll-like receptor signaling pathways</article-title>. <source>Front Immunol</source><volume>5</volume>:<fpage>112681</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00461</pub-id><pub-id pub-id-type="pmcid">PMC4174766</pub-id><pub-id pub-id-type="pmid">25309543</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pantapalangkoor</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Baquir</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Tomaras</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Reilly</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Barbacci</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Hujer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bonomo</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Fernandez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>REW</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>French</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Buslon</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Spellberg</surname><given-names>B</given-names></name>. <year>2012</year>. <article-title>Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis</article-title>. <source>mBio</source><volume>3</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mBio.00312-12</pub-id><pub-id pub-id-type="pmcid">PMC3518917</pub-id><pub-id pub-id-type="pmid">23033474</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knapp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wieland</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Florquin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pantophlet</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dijkshoorn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tshimbalanga</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Van Der Poll</surname><given-names>T</given-names></name>. <year>2006</year>. <article-title>Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia</article-title>. <source>Am J Respir Crit Care Med</source><volume>173</volume>:<fpage>122</fpage>&#8211;<lpage>129</lpage>.<pub-id pub-id-type="pmid">16210672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200505-730OC</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hazen</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hultgren</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2023</year>. <article-title>Catheterization triggers resurgent infection seeded by host Acinetobacter baumannii reservoirs</article-title>. <source>Sci Transl Med</source><volume>15</volume>:<fpage>eabn8134</fpage>.<pub-id pub-id-type="pmid">36630484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.abn8134</pub-id><pub-id pub-id-type="pmcid">PMC10464790</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dijkshoorn</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aucken</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Gerner-Smidt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kaufmann</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Ursing</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pitt</surname><given-names>TL</given-names></name>. <year>1993</year>. <article-title>Correlation of typing methods for Acinetobacter isolates from hospital outbreaks</article-title>. <source>J Clin Microbiol</source><volume>31</volume>:<fpage>702</fpage>&#8211;<lpage>705</lpage>.<pub-id pub-id-type="pmid">8458967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.31.3.702-705.1993</pub-id><pub-id pub-id-type="pmcid">PMC262847</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Luo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Baquir</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pantapalangkoor</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bonomo</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Doi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Spellberg</surname><given-names>B</given-names></name>. <year>2012</year>. <article-title>Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection</article-title>. <source>PLoS One</source><volume>7</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0029446</pub-id><pub-id pub-id-type="pmcid">PMC3254619</pub-id><pub-id pub-id-type="pmid">22253723</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Behairy</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Abdelrahman</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Toraih</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>EEDA</given-names></name>, <name name-style="western"><surname>Azab</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Sayed</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Hashem</surname><given-names>HR</given-names></name>. <year>2022</year>. <article-title>Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches</article-title>. <source>Int J Mol Sci</source><volume>23</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms231810982</pub-id><pub-id pub-id-type="pmcid">PMC9504743</pub-id><pub-id pub-id-type="pmid">36142893</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Nie</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Jing</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>BH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>XC</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jing</surname><given-names>CX</given-names></name>. <year>2015</year>. <article-title>Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a Southern Chinese population: A case-control study</article-title>. <source>Genetics and Molecular Research</source><volume>14</volume>:<fpage>8694</fpage>&#8211;<lpage>8705</lpage>.<pub-id pub-id-type="pmid">26345801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4238/2015.July.31.18</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chatzi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Papanikolaou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Makris</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Papathanasiou</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tsezou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Karvouniaris</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zakynthinos</surname><given-names>E</given-names></name>. <year>2018</year>. <article-title>Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece</article-title>. <source>J Crit Care</source><volume>47</volume>:<fpage>1</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">29860039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcrc.2018.05.012</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>S-H</given-names></name>, <name name-style="western"><surname>Teng</surname><given-names>C-K</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>M-C</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>K-Y</given-names></name>, <name name-style="western"><surname>Sheu</surname><given-names>C-C</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>S-J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>W-H</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>J-Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C-M</given-names></name>, <name name-style="western"><surname>Weng</surname><given-names>Z-X</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>C-K</given-names></name>. <year>2024</year>. <article-title>The impact and risk factors for developing pneumogenic bacteremia in carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia in the intensive care unit: A multicenter retrospective study</article-title>. <source>Int J Infect Dis</source><volume>146</volume>:<fpage>107128</fpage>.<pub-id pub-id-type="pmid">38852767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijid.2024.107128</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Van Faassen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>KuoLee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Conlan</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>. <year>2007</year>. <article-title>Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice</article-title>. <source>Infect Immun</source><volume>75</volume>:<fpage>5597</fpage>&#8211;<lpage>5608</lpage>.<pub-id pub-id-type="pmid">17908807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00762-07</pub-id><pub-id pub-id-type="pmcid">PMC2168347</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>. <year>2022</year>. <article-title>Neutrophil and Macrophage Response in Acinetobacter Baumannii Infection and Their Relationship to Lung Injury</article-title>. <source>Front Cell Infect Microbiol</source><volume>12</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2022.890511</pub-id><pub-id pub-id-type="pmcid">PMC9298752</pub-id><pub-id pub-id-type="pmid">35873147</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Grguric-Smith</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Gandhi</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Brennan</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>DeLeon-Rodriguez</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Coelho</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>LR</given-names></name>. <year>2015</year>. <article-title>Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model</article-title>. <source>Front Microbiol</source><volume>6</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2015.01134</pub-id><pub-id pub-id-type="pmcid">PMC4607880</pub-id><pub-id pub-id-type="pmid">26528277</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bruhn</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Pantapalangkoor</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Junus</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hujer</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Bonomo</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Spellberg</surname><given-names>B</given-names></name>. <year>2015</year>. <article-title>Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia</article-title>. <source>J Infect Dis</source><volume>211</volume>:<fpage>1296</fpage>&#8211;<lpage>1305</lpage>.<pub-id pub-id-type="pmid">25378635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiu593</pub-id><pub-id pub-id-type="pmcid">PMC4447835</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tsuchiya</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakao</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hirai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsujibo</surname><given-names>H</given-names></name>. <year>2012</year>. <article-title>NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia</article-title>. <source>Microbiol Immunol</source><volume>56</volume>:<fpage>107</fpage>&#8211;<lpage>116</lpage>.<pub-id pub-id-type="pmid">22145920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1348-0421.2011.00402.x</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>KuoLee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>. <year>2009</year>. <article-title>High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils</article-title>. <source>Microbes Infect</source><volume>11</volume>:<fpage>946</fpage>&#8211;<lpage>955</lpage>.<pub-id pub-id-type="pmid">19573619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micinf.2009.06.003</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Breslow</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Meissler</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hartzell</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Spence</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Truant</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gaughan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eisenstein</surname><given-names>TK</given-names></name>. <year>2011</year>. <article-title>Innate immune responses to systemic acinetobacter baumannii infection in mice: Neutrophils, but not interleukin-17, mediate host resistance</article-title>. <source>Infect Immun</source><volume>79</volume>:<fpage>3317</fpage>&#8211;<lpage>3327</lpage>.<pub-id pub-id-type="pmid">21576323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00069-11</pub-id><pub-id pub-id-type="pmcid">PMC3147579</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="other"><name name-style="western"><surname>Castro</surname><given-names>&#205;A</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Gnazzo</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D-H</given-names></name>, <name name-style="western"><surname>Van Dyken</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>L&#243;pez</surname><given-names>CB</given-names></name>. <year>2023</year>. <article-title>Murine Parainfluenza Virus Persists in Lung Innate Immune Cells Sustaining Chronic Lung Pathology</article-title>. <source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.11.07.566103</pub-id>.<pub-id pub-id-type="pmid">39358466</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brossard</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Campagnari</surname><given-names>AA</given-names></name>. <year>2012</year>. <article-title>The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells</article-title>. <source>Infect Immun</source><volume>80</volume>:<fpage>228</fpage>&#8211;<lpage>233</lpage>.<pub-id pub-id-type="pmid">22083703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.05913-11</pub-id><pub-id pub-id-type="pmcid">PMC3255684</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>P&#233;rez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Merino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rumbo-Feal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>&#193;lvarez-Fraga</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Vallejo</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Beceiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ohneck</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Mateos</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fern&#225;ndez-Puente</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Actis</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Poza</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bou</surname><given-names>G</given-names></name>. <year>2017</year>. <article-title>The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain</article-title>. <source>Virulence</source><volume>8</volume>:<fpage>959</fpage>&#8211;<lpage>974</lpage>.<pub-id pub-id-type="pmid">27858524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2016.1262313</pub-id><pub-id pub-id-type="pmcid">PMC5626241</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Astaneh</surname><given-names>SDA</given-names></name>, <name name-style="western"><surname>Rasooli</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gargari</surname><given-names>SLM</given-names></name>. <year>2017</year>. <article-title>Filamentous hemagglutinin adhesin FhaB limits A.baumannii biofilm formation</article-title>. <source>Front Biosci (Elite Ed)</source><volume>9</volume>:<fpage>266</fpage>&#8211;<lpage>275</lpage>.<pub-id pub-id-type="pmid">28199190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2741/e801</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Darvish Alipour Astaneh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rasooli</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Mousavi Gargari</surname><given-names>SL</given-names></name>. <year>2014</year>. <article-title>The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606(T)</article-title>. <source>Microb Pathog</source><volume>74</volume>:<fpage>42</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="pmid">25086432</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micpath.2014.07.007</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bentancor</surname><given-names>L V.</given-names></name>, <name name-style="western"><surname>Camacho-Peiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>C</surname><given-names>Bozkurt-Guzel</given-names></name>, <name name-style="western"><surname>Pier</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Maira-Litr&#225;n</surname><given-names>T</given-names></name>. <year>2012</year>. <article-title>Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii</article-title>. <source>J Bacteriol</source><volume>194</volume>:<fpage>3950</fpage>&#8211;<lpage>3960</lpage>.<pub-id pub-id-type="pmid">22609912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.06769-11</pub-id><pub-id pub-id-type="pmcid">PMC3416510</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weidensdorfer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hori</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Linke</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Djahanschiri</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Iruegas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ebersberger</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Riedel-Christ</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Enders</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Leukert</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kraiczy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rothweiler</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cinatl</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hipp</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kempf</surname><given-names>VAJ</given-names></name>, <name name-style="western"><surname>G&#246;ttig</surname><given-names>S</given-names></name>. <year>2019</year>. <article-title>The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii</article-title>. <source>Virulence</source><volume>10</volume>:<fpage>68</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="pmid">31874074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2018.1558693</pub-id><pub-id pub-id-type="pmcid">PMC6363060</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hatefi Oskuei</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Darvish Alipour Astaneh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rasooli</surname><given-names>I</given-names></name>. <year>2021</year>. <article-title>A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence</article-title>. <source>Arch Microbiol</source><volume>203</volume>:<fpage>3483</fpage>&#8211;<lpage>3493</lpage>.<pub-id pub-id-type="pmid">33907866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00203-021-02343-1</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tram</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Poole</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Jennings</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Eijkelkamp</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Atack</surname><given-names>JM</given-names></name>. <year>2021</year>. <article-title>The Acinetobacter baumannii Autotransporter Adhesin Ata Recognizes Host Glycans as High-Affinity Receptors</article-title>. <source>ACS Infect Dis</source><volume>7</volume>:<fpage>2352</fpage>&#8211;<lpage>2361</lpage>.<pub-id pub-id-type="pmid">34339169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsinfecdis.1c00021</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ishikawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakatani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hori</surname><given-names>K</given-names></name>. <year>2012</year>. <article-title>AtaA, a new member of the trimeric autotransporter adhesins from Acinetobacter sp. Tol 5 mediating high adhesiveness to various abiotic surfaces</article-title>. <source>PLoS One</source><volume>7</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0048830</pub-id><pub-id pub-id-type="pmcid">PMC3498257</pub-id><pub-id pub-id-type="pmid">23155410</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jackson-Litteken</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>NH</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Djahanschiri</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Distel</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Pardue</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Ebersberger</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2022</year>. <article-title>InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis</article-title>. <source>mBio</source><volume>13</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mbio.00258-22</pub-id><pub-id pub-id-type="pmcid">PMC9245377</pub-id><pub-id pub-id-type="pmid">35638734</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yesil</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yalcin</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Ogunc</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ongut</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ozhak</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Colak</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Er</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sarltas</surname><given-names>ZE</given-names></name>. <year>2022</year>. <article-title>Use of colistin with rifampicin, trimethoprim-sulfamethoxazole and teicoplanin in Acinetobacter mouse infection model</article-title>. <source>Future Microbiol</source><volume>17</volume>:<fpage>665</fpage>&#8211;<lpage>671</lpage>.<pub-id pub-id-type="pmid">35400195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/fmb-2021-0216</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>&#304;zci</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ture</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dinc</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yay</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Eren</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Bolat</surname><given-names>D</given-names></name>, <name name-style="western"><surname>G&#246;nen</surname><given-names>ZB</given-names></name>, <name name-style="western"><surname>&#220;n&#252;var</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Y&#305;ld&#305;z</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Aygen</surname><given-names>B</given-names></name>. <year>2023</year>. <article-title>The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model</article-title>. <source>European Journal of Clinical Microbiology and Infectious Diseases</source><volume>42</volume>:<fpage>1365</fpage>&#8211;<lpage>1372</lpage>.<pub-id pub-id-type="pmid">37814067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10096-023-04674-x</pub-id></mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dinc</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Demiraslan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Elmali</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Metan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Alp</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Doganay</surname><given-names>M</given-names></name>. <year>2014</year>. <article-title>Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis</article-title>. <source>Chemotherapy</source><volume>59</volume>:<fpage>325</fpage>&#8211;<lpage>329</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000356755</pub-id><pub-id pub-id-type="pmid">24525528</pub-id></mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nicasio</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Crandon</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Nicolau</surname><given-names>DP</given-names></name>. <year>2009</year>. <article-title>In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates</article-title>. <source>Antimicrob Agents Chemother</source><volume>53</volume>:<fpage>2756</fpage>.<pub-id pub-id-type="pmid">19364850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.01678-08</pub-id><pub-id pub-id-type="pmcid">PMC2704680</pub-id></mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Joly-Guillou</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Farinotti</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bryskier</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carbon</surname><given-names>C</given-names></name>. <year>2000</year>. <article-title>In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia</article-title>. <source>Journal of Antimicrobial Chemotherapy</source><volume>46</volume>:<fpage>827</fpage>&#8211;<lpage>830</lpage>.<pub-id pub-id-type="pmid">11062208</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/46.5.827</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Queenan</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>He</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>AS</given-names></name>. <year>2013</year>. <article-title>Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients</article-title>. <source>Journal of Chemotherapy</source><volume>25</volume>:<fpage>141</fpage>&#8211;<lpage>147</lpage>.<pub-id pub-id-type="pmid">23783138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/1973947813Y.0000000074</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Al-Madboly</surname><given-names>LA</given-names></name>. <year>2022</year>. <article-title>A Novel Triple Combination To Combat Serious Infections with Carbapenem-Resistant Acinetobacter baumannii in a Mouse Pneumonia Model</article-title>. <source>Microbiol Spectr</source><volume>10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.02710-21</pub-id><pub-id pub-id-type="pmcid">PMC9603289</pub-id><pub-id pub-id-type="pmid">35975993</pub-id></mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kang</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Berg</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Truelson</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Eliopoulos</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>McCoy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kirby</surname><given-names>JE</given-names></name>. <year>2018</year>. <article-title>Efficacy of apramycin against multidrug-resistant Acinetobacter baumannii in the murine neutropenic thigh model</article-title>. <source>Antimicrob Agents Chemother</source><volume>62</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.02585-17</pub-id><pub-id pub-id-type="pmcid">PMC5913965</pub-id><pub-id pub-id-type="pmid">29339396</pub-id></mixed-citation></ref><ref id="R75"><label>75.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Becker</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Aranzana-Climent</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nilsson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shariatgorji</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Haldimann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Platzack</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Andr&#233;n</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>B&#246;ttger</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Hobbie</surname><given-names>SN</given-names></name>. <year>2021</year>. <article-title>Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice</article-title>. <source>Clinical Microbiology and Infection</source><volume>27</volume>:<fpage>1315</fpage>&#8211;<lpage>1321</lpage>.<pub-id pub-id-type="pmid">33316399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmi.2020.12.004</pub-id></mixed-citation></ref><ref id="R76"><label>76.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chirkova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rosenborg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Palma Villar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lindberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hobbie</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Friberg</surname><given-names>LE</given-names></name>. <year>2022</year>. <article-title>Population pharmacokinetics of apramycin from first-in-human plasma and urine data to support prediction of efficacious dose</article-title>. <source>Journal of Antimicrobial Chemotherapy</source><volume>77</volume>:<fpage>2718</fpage>.<pub-id pub-id-type="pmid">35849148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkac225</pub-id><pub-id pub-id-type="pmcid">PMC9525081</pub-id></mixed-citation></ref><ref id="R77"><label>77.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ambrosi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scribano</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sarshar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zagaglia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Palamara</surname><given-names>AT</given-names></name>. <year>2020</year>. <article-title>Acinetobacter baumannii Targets Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAMs) for Invasion of Pneumocytes</article-title>. <source>mSystems</source><volume>5</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mSystems.00604-20</pub-id><pub-id pub-id-type="pmcid">PMC7762790</pub-id><pub-id pub-id-type="pmid">33361319</pub-id></mixed-citation></ref><ref id="R78"><label>78.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>An</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>W</given-names></name>. <year>2019</year>. <article-title>Acinetobacter baumannii outer membrane protein A induces HeLa cell autophagy via MAPK/JNK signaling pathway</article-title>. <source>Int J Med Microbiol</source><volume>309</volume>:<fpage>97</fpage>&#8211;<lpage>107</lpage>.<pub-id pub-id-type="pmid">30606692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijmm.2018.12.004</pub-id></mixed-citation></ref><ref id="R79"><label>79.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>L</given-names></name>. <year>2016</year>. <article-title>Critical role of bacterial isochorismatase in the autophagic process induced by Acinetobacter baumannii in mammalian cells</article-title>. <source>FASEB J</source><volume>30</volume>:<fpage>3563</fpage>&#8211;<lpage>3577</lpage>.<pub-id pub-id-type="pmid">27432399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.201500019R</pub-id><pub-id pub-id-type="pmcid">PMC5024702</pub-id></mixed-citation></ref><ref id="R80"><label>80.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bist</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dikshit</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Koh</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Mortellaro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Sukumaran</surname><given-names>B</given-names></name>. <year>2014</year>. <article-title>The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection</article-title>. <source>Infect Immun</source><volume>82</volume>:<fpage>1112</fpage>&#8211;<lpage>1122</lpage>.<pub-id pub-id-type="pmid">24366254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01459-13</pub-id><pub-id pub-id-type="pmcid">PMC3958010</pub-id></mixed-citation></ref><ref id="R81"><label>81.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Parra-Mill&#225;n</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Guerrero-G&#243;mez</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ayerbe-Algaba</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pach&#243;n-Ib&#225;&#241;ez</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Miranda-Vizuete</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pach&#243;n</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Smani</surname><given-names>Y</given-names></name>. <year>2018</year>. <article-title>Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB</article-title>. <source>mSphere</source><volume>3</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mSphere.00106-18</pub-id><pub-id pub-id-type="pmcid">PMC5874439</pub-id><pub-id pub-id-type="pmid">29600279</pub-id></mixed-citation></ref><ref id="R82"><label>82.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Maure</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Robino</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Van der Henst</surname><given-names>C</given-names></name>. <year>2023</year>. <article-title>The intracellular life of Acinetobacter baumannii</article-title>. <source>Trends Microbiol</source><volume>31</volume>:<fpage>1238</fpage>&#8211;<lpage>1250</lpage>.<pub-id pub-id-type="pmid">37487768</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2023.06.007</pub-id></mixed-citation></ref><ref id="R83"><label>83.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Asensio</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Rend&#243;n</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Burgas</surname><given-names>MT</given-names></name>. <year>2021</year>. <article-title>Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular Acinetobacter baumannii</article-title>. <source>Microorganisms</source><volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/microorganisms9020354</pub-id><pub-id pub-id-type="pmcid">PMC7916935</pub-id><pub-id pub-id-type="pmid">33670223</pub-id></mixed-citation></ref><ref id="R84"><label>84.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rumbo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tom&#225;s</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Moreira</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Carvajal</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Santillana</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Beceiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bou</surname><given-names>G</given-names></name>. <year>2014</year>. <article-title>The Acinetobacter baumannii Omp33&#8211;36 porin is a virulence factor that induces apoptosis and modulates autophagy in human cells</article-title>. <source>Infect Immun</source><volume>82</volume>:<fpage>4666</fpage>&#8211;<lpage>4680</lpage>.<pub-id pub-id-type="pmid">25156738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.02034-14</pub-id><pub-id pub-id-type="pmcid">PMC4249306</pub-id></mixed-citation></ref><ref id="R85"><label>85.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>An</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>W</given-names></name>. <year>2021</year>. <article-title>Acinetobacter baumannii up-regulates LncRNA-GAS5 and promotes the degradation of STX17 by blocking the activation of YY1</article-title>. <source>Virulence</source><volume>12</volume>:<fpage>1965</fpage>&#8211;<lpage>1979</lpage>.<pub-id pub-id-type="pmid">34304694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2021.1953851</pub-id><pub-id pub-id-type="pmcid">PMC8312602</pub-id></mixed-citation></ref><ref id="R86"><label>86.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kho</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Azad</surname><given-names>MAK</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schittenhelm</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Naderer</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Velkov</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Selkrig</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>. <year>2022</year>. <article-title>Correlative proteomics identify the key roles of stress tolerance strategies in Acinetobacter baumannii in response to polymyxin and human macrophages</article-title>. <source>PLoS Pathog</source><volume>18</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1010308</pub-id><pub-id pub-id-type="pmcid">PMC8887720</pub-id><pub-id pub-id-type="pmid">35231068</pub-id></mixed-citation></ref><ref id="R87"><label>87.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Smani</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Docobo-Pe&#341;ez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lo&#7765;ez-Rojas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Domi&#324;guez-Herrera</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ib&#225;&#241;ez-Mart&#237;nez</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pach&#243;n</surname><given-names>J</given-names></name>. <year>2012</year>. <article-title>Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells</article-title>. <source>J Biol Chem</source><volume>287</volume>:<fpage>26901</fpage>&#8211;<lpage>26910</lpage>.<pub-id pub-id-type="pmid">22689572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.344556</pub-id><pub-id pub-id-type="pmcid">PMC3411026</pub-id></mixed-citation></ref><ref id="R88"><label>88.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jacobs</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Hood</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Boyd</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Olson</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Carson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sayood</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iwen</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Skaar</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Dunman</surname><given-names>PM</given-names></name>. <year>2010</year>. <article-title>Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis</article-title>. <source>Infect Immun</source><volume>78</volume>:<fpage>1952</fpage>&#8211;<lpage>1962</lpage>.<pub-id pub-id-type="pmid">20194595</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00889-09</pub-id><pub-id pub-id-type="pmcid">PMC2863507</pub-id></mixed-citation></ref><ref id="R89"><label>89.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name>. <year>2021</year>. <article-title>Outer membrane protein a in Acinetobacter baumannii induces autophagy through mTOR signalling pathways in the lung of SD rats</article-title>. <source>Biomedicine &amp; Pharmacotherapy</source><volume>135</volume>:<fpage>111034</fpage>.<pub-id pub-id-type="pmid">33388597</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2020.111034</pub-id></mixed-citation></ref><ref id="R90"><label>90.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Stahl</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bergmann</surname><given-names>H</given-names></name>, <name name-style="western"><surname>G&#246;ttig</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ebersberger</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Averhoff</surname><given-names>B</given-names></name>. <year>2015</year>. <article-title>Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D</article-title>. <source>PLoS One</source><volume>10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0138360</pub-id><pub-id pub-id-type="pmcid">PMC4574555</pub-id><pub-id pub-id-type="pmid">26379240</pub-id></mixed-citation></ref><ref id="R91"><label>91.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tomlin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Piccinini</surname><given-names>AM</given-names></name>. <year>2018</year>. <article-title>A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens</article-title>. <source>Immunology</source><volume>155</volume>:<fpage>186</fpage>&#8211;<lpage>201</lpage>.<pub-id pub-id-type="pmid">29908065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imm.12972</pub-id><pub-id pub-id-type="pmcid">PMC6142291</pub-id></mixed-citation></ref><ref id="R92"><label>92.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wight</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Frevert</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Debley</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Reeves</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Parks</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Ziegler</surname><given-names>SF</given-names></name>. <year>2017</year>. <article-title>Interplay of Extracellular Matrix and Leukocytes in Lung Inflammation</article-title>. <source>Cell Immunol</source><volume>312</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">28077237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cellimm.2016.12.003</pub-id><pub-id pub-id-type="pmcid">PMC5290208</pub-id></mixed-citation></ref><ref id="R93"><label>93.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Onishi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kawamura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Higashino</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mimura</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tsukamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>S</given-names></name>. <year>2021</year>. <article-title>Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases</article-title>. <source>PLoS One</source><volume>16</volume>:<fpage>e0249300</fpage>.<pub-id pub-id-type="pmid">33793625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0249300</pub-id><pub-id pub-id-type="pmcid">PMC8016294</pub-id></mixed-citation></ref><ref id="R94"><label>94.</label><mixed-citation publication-type="webpage"><name name-style="western"><surname>Chapman</surname><given-names>HA</given-names></name>. <year>2012</year>. <source>Epithelial Responses to Lung Injury</source>. <pub-id pub-id-type="doi">10.1513/pats201112-053AW</pub-id> 9:<fpage>89</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="pmcid">PMC5830703</pub-id><pub-id pub-id-type="pmid">22802280</pub-id></mixed-citation></ref><ref id="R95"><label>95.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>&#197;hrman</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hallgren</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Malmstr&#246;m</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hedstr&#246;m</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Malmstr&#246;m</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bjermer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>XH</given-names></name>, <name name-style="western"><surname>Westergren-Thorsson</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Malmstr&#246;m</surname><given-names>J</given-names></name>. <year>2018</year>. <article-title>Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis</article-title>. <source>J Proteomics</source><volume>189</volume>:<fpage>23</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">29501846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jprot.2018.02.027</pub-id></mixed-citation></ref><ref id="R96"><label>96.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Booth</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Hadley</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cornett</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Dreffs</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Matthes</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Tsui</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Horowitz</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Fiore</surname><given-names>VF</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Niklason</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>White</surname><given-names>ES</given-names></name>. <year>2012</year>. <article-title>Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation</article-title>. <source>Am J Respir Crit Care Med</source><volume>186</volume>:<fpage>866</fpage>&#8211;<lpage>876</lpage>.<pub-id pub-id-type="pmid">22936357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201204-0754OC</pub-id><pub-id pub-id-type="pmcid">PMC3530219</pub-id></mixed-citation></ref><ref id="R97"><label>97.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Annoni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lancas</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tanigawa</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Matsushita</surname><given-names>MDM</given-names></name>, <name name-style="western"><surname>Fernezlian</surname><given-names>SDM</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Da Silva</surname><given-names>LFF</given-names></name>, <name name-style="western"><surname>Roughley</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Battaglia</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dolhnikoff</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hiemstra</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Sterk</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Rabe</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Mauad</surname><given-names>T</given-names></name>. <year>2012</year>. <article-title>Extracellular matrix composition in COPD</article-title>. <source>Eur Respir J</source><volume>40</volume>:<fpage>1362</fpage>&#8211;<lpage>1373</lpage>.<pub-id pub-id-type="pmid">22496324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00192611</pub-id></mixed-citation></ref><ref id="R98"><label>98.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>White</surname><given-names>ES</given-names></name>. <year>2015</year>. <article-title>Lung extracellular matrix and fibroblast function</article-title>. <source>Ann Am Thorac Soc</source><volume>12</volume>:<fpage>S30</fpage>&#8211;<lpage>S33</lpage>.<pub-id pub-id-type="pmid">25830832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201406-240MG</pub-id><pub-id pub-id-type="pmcid">PMC4430981</pub-id></mixed-citation></ref><ref id="R99"><label>99.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chang</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Tanino</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Vidova</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kinsella</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Wight</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Frevert</surname><given-names>CW</given-names></name>. <year>2014</year>. <article-title>A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease</article-title>. <source>Matrix Biol</source><volume>34</volume>:<fpage>1</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">24472738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.matbio.2014.01.011</pub-id><pub-id pub-id-type="pmcid">PMC4019684</pub-id></mixed-citation></ref><ref id="R100"><label>100.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Snyder</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Washington</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Birkland</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Frevert</surname><given-names>CW</given-names></name>. <year>2015</year>. <article-title>Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry</article-title>. <source>J Histochem Cytochem</source><volume>63</volume>:<fpage>952</fpage>&#8211;<lpage>967</lpage>.<pub-id pub-id-type="pmid">26385570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1369/0022155415610383</pub-id><pub-id pub-id-type="pmcid">PMC4823801</pub-id></mixed-citation></ref><ref id="R101"><label>101.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Niu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>. <year>2024</year>. <article-title>Bacterial persisters: molecular mechanisms and therapeutic development</article-title>. <source>Signal Transduction and Targeted Therapy 2024 9:1</source><volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-024-01866-5</pub-id><pub-id pub-id-type="pmcid">PMC11252167</pub-id><pub-id pub-id-type="pmid">39013893</pub-id></mixed-citation></ref><ref id="R102"><label>102.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wood</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Knabel</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>BW</given-names></name>. <year>2013</year>. <article-title>Bacterial Persister Cell Formation and Dormancy</article-title>. <source>Appl Environ Microbiol</source><volume>79</volume>:<fpage>7116</fpage>.<pub-id pub-id-type="pmid">24038684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AEM.02636-13</pub-id><pub-id pub-id-type="pmcid">PMC3837759</pub-id></mixed-citation></ref><ref id="R103"><label>103.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kunnath</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Suodha Suoodh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chellappan</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Chellian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Palaniveloo</surname><given-names>K</given-names></name>. <year>2024</year>. <article-title>Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update</article-title>. <source>Br J Biomed Sci</source><volume>81</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/bjbs.2024.12958</pub-id><pub-id pub-id-type="pmcid">PMC11335562</pub-id><pub-id pub-id-type="pmid">39170669</pub-id></mixed-citation></ref><ref id="R104"><label>104.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>. <year>2022</year>. <article-title>Essential Fitness Repertoire of Staphylococcus aureus during Co-infection with Acinetobacter baumannii In Vivo</article-title>. <source>mSystems</source><volume>7</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/msystems.00338-22</pub-id><pub-id pub-id-type="pmcid">PMC9600432</pub-id><pub-id pub-id-type="pmid">36040021</pub-id></mixed-citation></ref><ref id="R105"><label>105.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Timme</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wendler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Klassert</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Saraiva</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>da Rocha</surname><given-names>UN</given-names></name>, <name name-style="western"><surname>Wittchen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schramm</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ehricht</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Monecke</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Edel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>R&#246;del</surname><given-names>J</given-names></name>, <name name-style="western"><surname>L&#246;ffler</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ramirez</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Slevogt</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Figge</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Tuchscherr</surname><given-names>L</given-names></name>. <year>2024</year>. <article-title>Competitive inhibition and mutualistic growth in co-infections: deciphering Staphylococcus aureus-Acinetobacter baumannii interaction dynamics</article-title>. <source>ISME communications</source><volume>4</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ismeco/ycae077</pub-id><pub-id pub-id-type="pmcid">PMC11221087</pub-id><pub-id pub-id-type="pmid">38962494</pub-id></mixed-citation></ref><ref id="R106"><label>106.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Semenec</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cain</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Dawson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Dinh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lott</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Penesyan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maharjan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Short</surname><given-names>FL</given-names></name>, <name name-style="western"><surname>Hassan</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Paulsen</surname><given-names>IT</given-names></name>. <year>2023</year>. <article-title>Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence</article-title>. <source>Nat Commun</source><volume>14</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-36252-2</pub-id><pub-id pub-id-type="pmcid">PMC9911699</pub-id><pub-id pub-id-type="pmid">36759602</pub-id></mixed-citation></ref><ref id="R107"><label>107.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Krasauskas</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Skerni&#353;kyt&#279;</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Armalyt&#279;</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Su&#382;ied&#279;lien&#279;</surname><given-names>E</given-names></name>. <year>2019</year>. <article-title>The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system</article-title>. <source>BMC Microbiol</source><volume>19</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12866-019-1621-5</pub-id><pub-id pub-id-type="pmcid">PMC6833216</pub-id><pub-id pub-id-type="pmid">31690263</pub-id></mixed-citation></ref><ref id="R108"><label>108.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Repizo</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Gagn&#233;</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Foucault-Grunenwald</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Borges</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Charpentier</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Limansky</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Viale</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Salcedo</surname><given-names>SP</given-names></name>. <year>2015</year>. <article-title>Differential Role of the T6SS in Acinetobacter baumannii Virulence</article-title>. <source>PLoS One</source><volume>10</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0138265</pub-id><pub-id pub-id-type="pmcid">PMC4581634</pub-id><pub-id pub-id-type="pmid">26401654</pub-id></mixed-citation></ref><ref id="R109"><label>109.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weber</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Ly</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Irwin</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Pukatzki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2015</year>. <article-title>A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>112</volume>:<fpage>9442</fpage>&#8211;<lpage>9447</lpage>.<pub-id pub-id-type="pmid">26170289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1502966112</pub-id><pub-id pub-id-type="pmcid">PMC4522760</pub-id></mixed-citation></ref><ref id="R110"><label>110.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Storey</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McNally</surname><given-names>A</given-names></name>, <name name-style="western"><surname>&#197;strand</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>JPG</given-names></name>, <name name-style="western"><surname>Rodriguez-Escudero</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Elmore</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Palacios</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hobley</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Molina</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cid</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Salminen</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Bengoechea</surname><given-names>JA</given-names></name>. <year>2020</year>. <article-title>Klebsiella pneumoniae type VI secretion system-mediated microbial competition is PhoPQ controlled and reactive oxygen species dependent</article-title>. <source>PLoS Pathog</source><volume>16</volume>:<fpage>e1007969</fpage>.<pub-id pub-id-type="pmid">32191774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1007969</pub-id><pub-id pub-id-type="pmcid">PMC7108748</pub-id></mixed-citation></ref><ref id="R111"><label>111.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tsai</surname><given-names>CJY</given-names></name>, <name name-style="western"><surname>Loh</surname><given-names>JMS</given-names></name>, <name name-style="western"><surname>Proft</surname><given-names>T</given-names></name>. <year>2016</year>. <article-title>Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing</article-title>. <source>Virulence</source><volume>7</volume>:<fpage>214</fpage>&#8211;<lpage>229</lpage>.<pub-id pub-id-type="pmid">26730990</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2015.1135289</pub-id><pub-id pub-id-type="pmcid">PMC4871635</pub-id></mixed-citation></ref><ref id="R112"><label>112.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McGuffey</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jackson-Litteken</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Di Venanzio</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Distel</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>KQ</given-names></name>, <name name-style="western"><surname>Zaher</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Alfonzo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>NE</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>MF</given-names></name>. <year>2023</year>. <article-title>The tRNA methyltransferase TrmB is critical for Acinetobacter baumannii stress responses and pulmonary infection</article-title>. <source>mBio</source><volume>14</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mbio.01416-23</pub-id><pub-id pub-id-type="pmcid">PMC10653896</pub-id><pub-id pub-id-type="pmid">37589464</pub-id></mixed-citation></ref><ref id="R113"><label>113.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schneider</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Rasband</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Eliceiri</surname><given-names>KW</given-names></name>. <year>2012</year>. <article-title>NIH Image to ImageJ: 25 years of image analysis</article-title>. <source>Nat Methods</source><volume>9</volume>:<fpage>671</fpage>&#8211;<lpage>675</lpage>.<pub-id pub-id-type="pmid">22930834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.2089</pub-id><pub-id pub-id-type="pmcid">PMC5554542</pub-id></mixed-citation></ref><ref id="R114"><label>114.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoang</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Karkhoff-Schweizer</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Kutchma</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>HP</given-names></name>. <year>1998</year>. <article-title>A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants</article-title>. <source>Gene</source><volume>212</volume>:<fpage>77</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">9661666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1119(98)00130-9</pub-id></mixed-citation></ref><ref id="R115"><label>115.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pontes</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Groisman</surname><given-names>EA</given-names></name>. <year>2019</year>. <article-title>Slow growth dictates non-heritable antibiotic resistance in Salmonella enterica</article-title>. <source>Sci Signal</source><volume>12</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scisignal.aax3938</pub-id><pub-id pub-id-type="pmcid">PMC7206539</pub-id><pub-id pub-id-type="pmid">31363068</pub-id></mixed-citation></ref><ref id="R116"><label>116.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ducas-Mowchun</surname><given-names>K</given-names></name>, <name name-style="western"><surname>De Silva</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Crisostomo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fernando</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Pelka</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name>. <year>2019</year>. <article-title>Next Generation of Tn 7-Based Single-Copy Insertion Elements for Use in Multi- and Pan-Drug-Resistant Strains of Acinetobacter baumannii</article-title>. <source>Appl Environ Microbiol</source><volume>85</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AEM.00066-19</pub-id><pub-id pub-id-type="pmcid">PMC6532044</pub-id><pub-id pub-id-type="pmid">30902859</pub-id></mixed-citation></ref><ref id="R117"><label>117.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Harding</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Tracy</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Carruthers</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Rather</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Actis</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Munson</surname><given-names>RS</given-names></name>. <year>2013</year>. <article-title>Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility</article-title>. <source>mBio</source><volume>4</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mBio.00360-13</pub-id><pub-id pub-id-type="pmcid">PMC3735195</pub-id><pub-id pub-id-type="pmid">23919995</pub-id></mixed-citation></ref><ref id="R118"><label>118.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Carruthers</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Nicholson</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Tracy</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Munson</surname><given-names>RS</given-names></name>. <year>2013</year>. <article-title>Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition</article-title>. <source>PLoS One</source><volume>8</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0059388</pub-id><pub-id pub-id-type="pmcid">PMC3602014</pub-id><pub-id pub-id-type="pmid">23527179</pub-id></mixed-citation></ref><ref id="R119"><label>119.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dalton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cortez-Cordova</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>HP</given-names></name>. <year>2010</year>. <article-title>Mini-Tn7 vectors as genetic tools for single copy gene cloning in Acinetobacter baumannii</article-title>. <source>J Microbiol Methods</source><volume>82</volume>:<fpage>296</fpage>&#8211;<lpage>300</lpage>.<pub-id pub-id-type="pmid">20638421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mimet.2010.07.002</pub-id></mixed-citation></ref><ref id="R120"><label>120.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Leus</surname><given-names>I V.</given-names></name>, <name name-style="western"><surname>Adamiak</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Trinh</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Zgurskaya</surname><given-names>HI</given-names></name>. <year>2020</year>. <article-title>Inactivation of AdeABC and AdeIJK efflux pumps elicits specific nonoverlapping transcriptional and phenotypic responses in Acinetobacter baumannii</article-title>. <source>Mol Microbiol</source><volume>114</volume>:<fpage>1049</fpage>&#8211;<lpage>1065</lpage>.<pub-id pub-id-type="pmid">32858760</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/mmi.14594</pub-id></mixed-citation></ref><ref id="R121"><label>121.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Leus</surname><given-names>I V.</given-names></name>, <name name-style="western"><surname>Weeks</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Bonifay</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Richardson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zgurskaya</surname><given-names>HI</given-names></name>. <year>2018</year>. <article-title>Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii</article-title>. <source>J Bacteriol</source><volume>200</volume>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.00049-18</pub-id><pub-id pub-id-type="pmcid">PMC5996695</pub-id><pub-id pub-id-type="pmid">29661860</pub-id></mixed-citation></ref><ref id="R122"><label>122.</label><mixed-citation publication-type="other">M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application.</mixed-citation></ref><ref id="R123"><label>123.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Figurski</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Helinski</surname><given-names>DR</given-names></name>. <year>1979</year>. <article-title>Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>76</volume>:<fpage>1648</fpage>&#8211;<lpage>1652</lpage>.<pub-id pub-id-type="pmid">377280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.76.4.1648</pub-id><pub-id pub-id-type="pmcid">PMC383447</pub-id></mixed-citation></ref><ref id="R124"><label>124.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Choi</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Gaynor</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>White</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bosio</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Karkhoff-Schweizer</surname><given-names>RAR</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>HP</given-names></name>. <year>2005</year>. <article-title>A Tn7-based broad-range bacterial cloning and expression system</article-title>. <source>Nat Methods</source><volume>2</volume>:<fpage>443</fpage>&#8211;<lpage>448</lpage>.<pub-id pub-id-type="pmid">15908923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth765</pub-id></mixed-citation></ref><ref id="R125"><label>125.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>HUGH</surname><given-names>R</given-names></name>, <name name-style="western"><surname>REESE</surname><given-names>R</given-names></name>. <year>1968</year>. <article-title>A comparison of 120 strains of Bacterium anitratum Schaub and Hauber with the type strain of this species</article-title>. <source>Int J Syst Evol Microbiol</source><volume>18</volume>:<fpage>207</fpage>&#8211;<lpage>229</lpage>.</mixed-citation></ref><ref id="R126"><label>126.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>DUTHIE</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>LORENZ</surname><given-names>LL</given-names></name>. <year>1952</year>. <article-title>Staphylococcal coagulase; mode of action and antigenicity</article-title>. <source>J Gen Microbiol</source><volume>6</volume>:<fpage>95</fpage>&#8211;<lpage>107</lpage>.<pub-id pub-id-type="pmid">14927856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/00221287-6-1-2-95</pub-id></mixed-citation></ref><ref id="R127"><label>127.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rosen</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Hooton</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Stamm</surname><given-names>WE</given-names></name>, <name name-style="western"><surname>Humphrey</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Hultgren</surname><given-names>SJ</given-names></name>. <year>2007</year>. <article-title>Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection</article-title>. <source>PLoS Med</source><volume>4</volume>:<fpage>1949</fpage>&#8211;<lpage>1958</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.0040329</pub-id><pub-id pub-id-type="pmcid">PMC2140087</pub-id><pub-id pub-id-type="pmid">18092884</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p id="P34">Low inoculums of modern respiratory <italic toggle="yes">A. baumannii</italic> clinical isolates result in chronic lung infection in <italic toggle="yes">tlr4</italic> mutant mice. Groups of C3H/HeN (WT) or C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were intranasally inoculated with 10<sup>8</sup> G636 (A), 10<sup>8</sup> G654 (B), 10<sup>8</sup>
<italic toggle="yes">Ab</italic>19606 (C), 10<sup>5</sup> G636 (D), 10<sup>5</sup> G654 (E), or 10<sup>5</sup>
<italic toggle="yes">Ab</italic>19606 (F). Beginning at 24 hpi, groups of mice were sacrificed every three days, and bacteria in the lungs were quantified. Each data point indicates and individual mouse.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0001.jpg"/></fig><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p id="P35">Lower intranasal <italic toggle="yes">A. baumannii</italic> inoculums result in reduced lung neutrophil influx. Groups of C3H/HeN (WT) or C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were intranasally inoculated with 10<sup>5</sup> G636, 10<sup>8</sup> G636, or mock inoculated with PBS. At 4 h (A and D), 2 d (B and E), and 7 d (C and F) pi, <underline>a</underline>lveolar <underline>m</underline>acrophages (AMs) (A-C) and <underline>p</underline>oly<underline>m</underline>orpho<underline>n</underline>uclear leukocytes (PMNs) (D-F) in the BALF were enumerated by flow cytometry. Shown are pooled results from at least two independent experiments, and each data point represents an individual mouse. The horizontal line represents the mean, and the <underline>s</underline>tandard <underline>e</underline>rror of the <underline>m</underline>ean (SEM) is indicated by error bars. *<italic toggle="yes">P</italic> &lt; 0.05; two-way <underline>an</underline>alysis <underline>o</underline>f <underline>va</underline>riance (ANOVA), Tukey&#8217;s test for multiple comparisons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0002.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p id="P36">The chronic respiratory infection model results in lung pathology. Groups of C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were inoculated with 10<sup>5</sup> G636 or mock-inoculated with PBS, and at 4 hpi, 2 dpi, 7 dpi, 14 dpi, and 21 dpi, lungs slices were prepared, H&amp;E stained, and scored for alveolitis (A), peribronchiolitis (B), smooth muscle hypertrophy (C), squamous epithelium metaplasia (D), and BALT formation (E). The mean is shown on the graph, and the SEM is indicated by error bars. *<italic toggle="yes">P</italic> &lt; 0.05, Unpaired Student&#8217;s <italic toggle="yes">t</italic>-test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0003.jpg"/></fig><fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><p id="P37">InvL is a critical virulence factor for long-term respiratory infection, but dispensable in the acute infection model. C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were infected with 10<sup>5</sup> G636, G636 &#916;<italic toggle="yes">invL</italic>, or G636 <italic toggle="yes">invL</italic><sup>+</sup>. Groups of mice were then sacrificed at 1 dpi (A), 7 dpi (B), 14 dpi (C), and 21 dpi (D), and CFU in the lungs were quantified. Shown are the results from 3 independent experiments. For the acute infection model, groups of C57BL/6 mice were infected with 10<sup>9</sup> G636, G636 &#916;<italic toggle="yes">invL</italic>, or G636 <italic toggle="yes">invL</italic><sup>+</sup>. 24 hpi, mice were sacrificed, and CFU in the lungs (A), spleen (B), and kidneys (C) were enumerated. Each data point represents an individual mouse, the horizontal line represents the mean, and the SEM is indicated by error bars. Shown are the results of 2&#8211;3 independent experiments. *<italic toggle="yes">P</italic> &lt; 0.05; Kruskal-Wallis <italic toggle="yes">H</italic> test with Dunn&#8217;s test for multiple comparisons; ns = not significant.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0004.jpg"/></fig><fig position="float" id="F5" orientation="portrait"><label>Figure 5.</label><caption><p id="P38">The chronic respiratory infection model can be used to study outcomes of antibiotic treatment. Groups of C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were infected with 10<sup>5</sup> G636 (A, C) or 10<sup>5</sup> G654 (B, D) and sacrificed at 1, 3, and 5 dpi (long-term). Additionally, groups of C57Bl/6 mice were infected with 10<sup>9</sup> G636 (A, C) or 10<sup>9</sup> G654 (B, D) and sacrificed at 24 hpi (acute). Mice in both infection models were treated intraperitoneally treated with PBS or 100 mg/kg <underline>tig</underline>ecycline (tig) every 12 h (A, B) or PBS or 500 mg/kg <underline>apr</underline>amycin (apr) every 12 h (C, D) with all treatments beginning 4 hpi. At each timepoint, CFU were quantified in the lungs. Shown are the results from at least two independent experiments, each data point represents an individual mouse, the horizontal line represents the mean, and the SEM is represented by error bars. *<italic toggle="yes">P</italic> &lt; 0.05; Mann-Whitney <italic toggle="yes">U</italic> test.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0005.jpg"/></fig><fig position="float" id="F6" orientation="portrait"><label>Figure 6.</label><caption><p id="P39">Bacterial secondary infection alters the course of chronic <italic toggle="yes">A. baumannii</italic> pneumonia. C3H/HeJ (<italic toggle="yes">tlr4</italic> mutant) mice were intranasally inoculated with 10<sup>5</sup> G636, and groups of mice were sacrificed at 1, 7, and 14 dpi. At 14 days post-<italic toggle="yes">A. baumannii</italic> infection, groups of mice were either not inoculated (untreated), inoculated with PBS (mock-infected), infected with <italic toggle="yes">S. aureus</italic>, or infected on <italic toggle="yes">K. pneumoniae</italic>. Subsequently, on days 15 and 16 post-<italic toggle="yes">A. baumannii</italic> infection (1 and 2 days post-secondary infection), mice were sacrificed, and <italic toggle="yes">A. baumannii</italic> CFU were quantified in the lungs (A, D, E), spleen (B), and kidneys (C). In panels A, B, and C, each data point represents the mean, the SEM is represented by error bars, and the limit of detection is indicated by the dashed line. In panels D and E, each data point represents an individual mouse, the horizontal line represents the mean, and the SEM is indicated by error bars. Shown are results from at least 2 independent experiments. *<italic toggle="yes">P</italic> &lt; 0.05; Kruskal-Wallis <italic toggle="yes">H</italic> test with Dunn&#8217;s test for multiple comparisons.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2024.09.17.613469v2-f0006.jpg"/></fig></floats-group></article></pmc-articleset>